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Abstract: Several studies indicated how dietary patterns that were obtained from nutritional
cluster analysis can predict disease risk or mortality. Low-grade chronic inflammation represents
a background pathogenetic mechanism linking metabolic risk factors to increased risk of chronic
degenerative diseases. A Mediterranean diet (MeDi) style has been reported as associated with
a lower degree of inflammation biomarkers and with a protective role on cardiovascular and
cerebrovascular events. There is heterogeneity in defining the MedDiet, and it can, owing to its
complexity, be considered as an exposome with thousands of nutrients and phytochemicals. Recently,
it has been reported a novel positive association between baseline plasma ceramide concentrations
and cardiovascular events and how adherence to a Mediterranean Diet-style may influence the
potential negative relationship between elevated plasma ceramide concentrations and cardiovascular
diseases (CVD). Several randomized controlled trials (RCTs) showed the positive effects of the MeDi
diet style on several cardiovascular risk factors, such as body mass index, waist circumference, blood
lipids, blood pressure, inflammatory markers and adhesion molecules, and diabetes and how these
advantages of the MeDi are maintained in comparison of a low-fat diet. Some studies reported
a positive effect of adherence to a Mediterranean Diet and heart failure incidence, whereas some
recent studies, such as the PREDIMED study, showed that the incidence of major cardiovascular
events was lower among those assigned to MeDi supplemented with extra-virgin olive oil or nuts
than among those assigned to a reduced-fat diet. New studies are needed to better understand
the molecular mechanisms, whereby the MedDiet may exercise its effects. Here, we present recent
advances in understanding the molecular basis of MedDiet effects, mainly focusing on cardiovascular
diseases, but also discussing other related diseases. We review MedDiet composition and assessment
as well as the latest advances in the genomic, epigenomic (DNA methylation, histone modifications,
microRNAs, and other emerging regulators), transcriptomic (selected genes and whole transcriptome),
and metabolomic and metagenomic aspects of the MedDiet effects (as a whole and for its most
typical food components). We also present a review of the clinical effects of this dietary style
underlying the biochemical and molecular effects of the Mediterranean diet. Our purpose is to review
the main features of the Mediterranean diet in particular its benefits on human health, underling
the anti-inflammatory, anti-oxidant and anti-atherosclerotic effects to which new knowledge about
epigenetic and gut-microbiota relationship is recently added.
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1. Introduction: The Rediscovery of Mediterranean Diet
Diet constitutes one of the most relevant environmental factors that influence the development of
several chronic age-related diseases. People should learn how to control dietary approach in order to
choose those patterns that are associated to promotion of health and prevention of diet-related disease.
Nutrition research has analysed the role of single nutrient with regard of health for several years.
Recent knowledge regarding the complex synergistic interactions among nutrients and other food
constituents has led to an increased interest in total dietary patterns. The concept of “dietary patterns”
has been developed to express a broader and wider analysis of food and nutrient consumption. Among
the complex network of interactions existing between genome and epigenetic factors, the application
of dietary patterns might thus offer more useful information about the risk to develop some diseases,
in particular cardiovascular or cerebrovascular diseases, than single food or nutrient. In this way,
several studies indicated how dietary patterns that were obtained from nutritional cluster analysis
were able to predict disease risk or mortality [1,2]. Dietary pattern analysis has been pinpointed in
the last ten years as a promising and practical approach to evaluate the link between diet and the risk
of chronic diseases. Interestingly, dietary pattern research has a developing interest with regard of
nutrition policy, particularly as it demonstrates the importance of total diet in health promotion.
Looking at individual nutrients or foods is a partial way that it has been changed by a pattern
analysis evaluating the effects of overall diet style. Furthermore, there is growing interest in applying
the evaluation of dietary quality indices to study whether adherence to a particular dietary pattern or
current dietary guidelines is associated to the risk of disease.
To date, the traditional Mediterranean diet is a well-known and well-studied healthy dietary
pattern and many evidences underling how this could represent a central useful tool to control
cardiovascular risk factors, such as hypercholesterolemia, diabetes, hypertension [3].
The Seven Countries study, which was a research project that enrolled more than 12,000 men
of Finland, Greece, Italy, Japan, Holland, the United States, and Yugoslavia, reported the important
role of diet as risk factor for cardiovascular diseases. Of these seven nations, the United States and
Finland had the highest animal product consumption, the highest saturated fat intake, the highest
cholesterol consumption, and the highest incidence of death from cardiovascular diseases. On the
contrary, the Mediterranean countries and Japan showed an opposite trend of cardiovascular event
incidence [4].
The Mediterranean diet was reported to present an inverse association with the incidence of
coronary artery disease in Southern Europe in comparison with Northern Europe and the United
States [5,6]. In the light of these findings, Dr. Ancel Keys discovered (or rediscovered) the Mediterranean
diet as a possible healthy diet. In a retrospective article, he described it as ‘a mainly vegetarian die
favouring fruit for dessert’.
The Mediterranean diet refers to an eating pattern of the olive growing areas surrounding the
Mediterranean Sea. It has been considered to be a “poor man’s” diet, developed over the centuries,
as people laboured in order to create sustenance in less hospitable terrain.
This dietary style emphasizes fruits, root vegetables, grains (mostly whole), legumes, nuts, seeds,
and olive oil, which represents a hallmark of this dietary pattern, providing a considerable content of
monounsaturated fatty acids and reduced intake of saturated fatty acids; moreover, it is characterized
by a moderate intake of red wine with meals, a moderate intake of seafood, poultry, dairy products,
and low consumption of red meat and sweets. Two typical aspects of a Mediterranean lifestyle include
daily physical activity and adequate hydration [3].
In 1995 Ancel Keys affirmed “What is the Mediterranean Diet? One definition might be that it is
what the Mediterranean natives eat. But as we know and think of it now, it is a relatively new invention.
Tomatoes, potatoes, and beans, for example, came from America long after Christopher Columbus
discovered the New World. I noticed that the heart of what was considered the Mediterranean Diet
is mainly vegetarian: pasta in many forms, leaves sprinkled with olive oil, all kinds of vegetables in
season, and often cheese, all finished off with fruit, and frequently washed with wine” [7].
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More recently two researchers fully involved in the study of the cardiovascular effects of
Mediterranean diet said that “The term ‘Mediterranean’ diet refers to dietary patterns found in
olive-growing areas of the Mediterranean region and described in the 1960s and beyond. There are
several variants of the Mediterranean diet, but some common components can be identified: high
monounsaturated/saturated fat ratio; ethanol consumption at moderate levels and mainly in the form
of wine; high consumption of vegetables, fruits, legumes, and grains; moderate consumption of milk
and dairy products, mostly in the form of cheese; and low consumption of meat and meat products” [8].
The Mediterranean diet became part of UNESCO’s intangible cultural heritage in 2010.
This distinction highlights the critical role played by this way of eating in the culture and identity
of four communities in the Mediterranean basin: Cilento (Italy), Coron (Greece), Soria (Spain) and
Chefchaouen (Morocco). In December 2013, other geographic places were added: Agros (Cyprus),
Hvar and Brac (Croatia) and Tavira (Portugal). According to UNESCO’s definition, the Mediterranean
diet constitutes “a set of skills, knowledge, rituals, symbols and traditions concerning crops, harvesting, fishing,
animal husbandry, conservation, processing, cooking, and particularly the sharing and consumption of food.”
The present-day lifestyle is characterised by high availability of food and an ever-increasing rate
of physical inactivity leading to a situation of apparent psycho-physical well-being, which, however,
often does not correspond with the real state of health. The typical eating habits of the Mediterranean
populations have been progressively enriched with high-protein foods, saturated fats, and sugars
to the point, where intake now exceeds the necessary intake levels. Thus, we are living in an age of
“apparent well-being”, where the increase in life expectancy runs parallel to the increase in the risk of
diseases such as obesity, metabolic syndrome, cardiovascular disease, and cancer.
Talking about Mediterranean diet not only referred to a dietary pattern, but we also want to stress
the role of the “Mediterranean-lifestyle”, which, among several characteristics, includes psychosocial
factors, such as interpersonal and family relationships, friendships, enjoying the conviviality of the
hosts and other guests; in fact, the new pyramid of the Modern Mediterranean diet, addressed to
individuals from 18 to 65 years of age, takes the evolution of society into consideration, highlights the
fundamental importance of engaging in physical activity and conviviality, the importance of taking a
short nap in the early afternoon, habit that takes different names, depending on the country (siesta,
riposo, pennichella), the importance of drinking water, and lays emphasis on the consumption of local
seasonal food products.
It is a Mediterranean diet that has been revised in the light of modernity and well-being, but it
also allows for the various cultural and religious traditions and different national identities. The new
pyramid is a simple mainframe, which can be adapted to the current needs of the Mediterranean
people concerning all local variants of the Mediterranean diet (Figure 1).
The Mediterranean diet is not a homogenous and exclusive model among the 16 countries that
are situated around the Mediterranean Sea (Figure 2). Despite fruit, vegetables, cereals, olive oil
are typical food of the Mediterranean diet each country has its own dietary habits influenced by
socio-cultural, religious, and economic factors. For example, pork that is one of the most frequent
types of meat consumed in European countries of the Mediterranean basin [9], is rejected in Muslim
countries on religious grounds. Typical Mediterranean fermented beverages as wine are excluded in
Muslim countries, which have a higher consumption of tea and fruit juices. Another difference has
been observed regarding virgin olive oil consumption that is low in countries of the Middle East and
Northern Africa in comparison to Spain, Italy, or Greece.
Mediterranean populations, such as Greece, Italy, and the Mediterranean coastal regions of France
and Spain, adopt a food model that contains the typical meals of the Mediterranean dietary pattern,
however they have preserved their eating habits over the years. These differences are especially evident
when comparing the characteristics of the main meals in the four Mediterranean countries.
Pasta, which is one of the main foods of the Mediterranean diet pattern, is more widespread in
Italy, where it is always present in the main meals. Another important food is bread, which is often
served after pasta in Italy. Greeks often serve a bowl with olive oil together with bread.
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Greek population prefers stews vegetables and meat without the addition of rice or potatoes, usually
served separately.
Eggs are widespread in the main Spanish meals, a tradition that distinguishes them from the other
Mediterranean populations. In France, in most cases, cuisines, such as pâté or other processed sauces,
are served at the beginning of the meal.
Greek and Spanish populations both consume fewer cheeses than the other two Mediterranean
populations. However, the amount of feta that is present in the green salad, a typically Greek dish that
also includes olives and olive oil, makes this dish a single dish.
In the Mediterranean populations, the salads are very-common dishes, which are quite simple
because they are not very rich in ingredients and frequently seasoned with olive oil and vinegar.
A typical habit of Provence and Spain is to put them on the table at the beginning and then to serve
them before the main course, unlike other Mediterranean countries. A salad that is common from
the Strait of Gibraltar to Eastern Greece, it provides any variety of lettuce seasoned with a little salt,
a couple of drops of vinegar, and abundant olive oil [10].
Even though the geographical position of Portugal, which is not in the Mediterranean basin,
Mediterranean diet is an integral part of cultural heritage of Portuguese population; this is prevalently
due to ancestral influences from the Mediterranean neighbours and from migrants. The Portuguese
diet is also influenced by cultural factors, socio-economic context, genetic background, and increased
availability of fish due to its wide Atlantic coast. However, several factors have contributed to
withdrawing the Portuguese population from traditional dietary habits, for example European Union
agriculture policies and financial capacity to afford foods of quality reported by Portuguese population.
According to recent ecological studies, Portugal has experienced a relevant decrease in Mediterranean
diet adherence over the last decades. A consequence of this trend is the inexorable increase of obesity,
as it was observed in women of childbearing age and pregnant women [11].
North African countries bordering the Mediterranean Sea share dietary habits that are typical of
European Mediterranean countries. However, these customs are influenced by social and economic
changes. In the Moroccan population it has been described a higher consumption of bottled water,
infusions, and juices [12].
Benhammou et al. compared the dietary customs of three Mediterranean populations (Spain,
Morocco, and Palestine) with different cultures and lifestyles, but are influenced by the same geographic
context, The adherence to Mediterranean diet was evaluated through MD Serving Score (MDSS).
After the analysis of the questionnaires, which were administered to all participants, they described a
moderate adherence to the Mediterranean dietary pattern in all populations. In comparison to the
Palestine population, MDSS-assessed adherence to the Mediterranean diet was 6.36-fold higher in the
Spanish population and 3.88-fold higher in the Moroccan population.
The Spanish diet appeared to be closer to Mediterranean recommendations than the diet of
Morocco or Palestine.
Common components were fruit, vegetables, olive oil, while fish and alcohol did not appear in
the Lebanese dietary pattern.
In Spain, it was described a high intake in proteins and lipids and low in carbohydrates; on the
other hand, carbohydrate intake was higher and protein intake lower in Palestine than in Spain or
Morocco [13]. Belahsen et al. also showed a high- carbohydrate intake in Egypt, Jordan, Libya, Tunisia,
and Algeria, with reduced fat intake in comparison to the MD recommendation (Food and Agriculture
Organization, FAO, 2005) [14].
In the Palestinian population, it was reported a reduced calcium consumption, which may be a
consequence of their low dairy product consumption. Moreover, Palestinian participants had a very
low iodine intake in comparison to Spanish and Moroccan populations. Additionally, FAO reports
have pointed out iodine deficiency in Palestine and Morocco: it likely is responsible a more limited
access to iodized salt in these countries (FAO, 2005; FAO, 2011).
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The findings of this study could be explained by the low intake of vegetables, fish, and dairy
products by the Palestinians. In conclusion, the diet of the Spanish participants is closer to MD
recommendations in comparison to the diets of the Moroccans and Palestinians, despite the three
groups belonging to the Mediterranean basin [15]. Currently, a debate exists about the adherence to
the Mediterranean diet in modern Greece and Cyprus: their diet is the same traditional Mediterranean
diet or these countries have moved toward a more Westernised diet? According to the results of recent
ecological studies, Greece shows the most relevant drop in the Mediterranean dietary pattern over the
last decades.
A systematic review by Kyriacou A. et al. examined the current evidences regarding the adherence
of the Greek and Cypriot population to the Mediterranean diet.
All of the studies reported consistent moderate adherence to the Mediterranean diet. These results
were independently observed, whether the original Mediterranean diet score and cut-off points were
applied or whether results were converted to percentages and tertiles were used as the cut-off points.
This systematic review suggests that adherence to the Mediterranean diet has decreased since
the 1950s and 1960s, when it was high by definition. This observation could be related to a recent
changed interest from single nutrients to whole diets in the last decade [16]. For example, Dedoussis
et al. described, after an analysis of elderly subjects from five different countries, that Greece had a
statistically significant lower Mdiet score when compared with Italy, a higher one than Poland, but no
appreciable difference from Germany and France [17]. Van Diepen et al. compared the Mdiet score of
Greek and Dutch university students. The results of this study showed an unexpected more increased
statistically significant adherence in favour of the non-Mediterranean origin Dutch students [18].
In the light of these recent studies, the observed change in the diet of Greek population seems to
reflect a transition from the traditional Mediterranean diet to a more Westernized diet, thus partially
explaining the worsening in the health of this country. Recently, it has been observed a relentless
increase in the incidence of diseases as diabetes, obesity cardiovascular disease, some cancers,
and dyslipidaemia [19]. Other contributing non-diet related factors are the high prevalence of smoking
and reduced physical activity observed in the Greek population [20].
Given the well-known beneficial healthy actions of the Mediterranean diet, public health and
education measures should be implemented to reverse this trend [21].
With regard to Croatia, results from a recent study suggest that differences in dietary intake and
food choices are becoming less noticeable in rural versus urban parts and are less geographically
dependent with “westernized diet” taking place instead of a “traditional diet”. This study, which was
conducted in school aged children, reported that the prevalence of obesity among Croatian children
was high and unrelated to an urban/rural setting. It is necessary to coordinate the role of family
together with educational institutions and health professionals in order to interrupt this raising negative
trend [22].
In respect of the well-established impact of good dietary habits on the prevention of cardiovascular
diseases and other chronic diseases, health policies should focus on adherence to a healthy diet,
as Mediterranean diet, supporting traditional dietary patterns in a period of intense commercial pressures.
In the light of the above-mentioned considerations, we would review the main effects of the
Mediterranean diet, especially on inflammation, atherosclerosis, and cardiovascular diseases.
2. Biological Effects of Mediterranean Diet
Over the years, several studies have been carried out on the effects of the Mediterranean
Diet, some of which have been relevant in order to know the mechanisms that could explain the
potentially beneficial role of the Mediterranean Diet for the prevention of cardiovascular disease
(CVD). In this setting, the biomolecular mechanisms that seem to promote long-term health effects
of the Mediterranean diet are the following: lipid-lowering effect; protection from oxidative stress,
inflammation and platelet aggregation; inhibition of nutrient sensitization pathways through specific
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restriction of amino acids and production of intestinal metabolites that are mediated by the microbiota
(increase in genome stability).
2.1. Role of Genome
The knowledge of the gene-diet interaction might allow to better clarifying the mechanisms
through which a modifiable factor as diet influences gene expression. Accumulating data are emerging
about the different responses of individuals with different genotypes to diet; the study of genetic
predisposition might provide a tool to detect those subjects who may benefit from intervention on
dietary patterns.
The first studied gene in order to identify the genetic variants associated to a high susceptibility
to cardiovascular disease was the gene encoding ACE (angiotensin converting enzyme). This study
reported that homozygous individuals for a deletion in the chosen gene presented a superior risk of
myocardial infarction. APOE gene is another example of studying genetic variants that are related to
susceptibility to cardiovascular disease, and still the CEPT (cholesterol ester transfer protein) gene was
studied in animal models and human studies demonstrating its role in reverse cholesterol transport,
thus influencing proatherogenic and antiatherogenic processes [23,24].
The genome wide approach intends to search some associations between many SNPs and diseases.
Single nucleotide polymorphism (SNPs) are common genetic variants that are detected through
methods of genotypization in the DNA sequence. An important goal of GWAS (genome wide association
study) is to understand and investigate the relationship between single nucleotide polymorphisms
and phenotypes [25].
In the field of the studies regarding Mediterranean diet the results of the PREDIMED trial highlight
the strict influence of the dietary components on genetic predisposition towards cardiovascular risk.
In this regard, Carella and colleagues studied the rs7903146 polymorphism in the transcription factor
7-like2 gene; in particular, they reported a relationship between the genetic predisposition to present
hypercholesterolemia, hypertriglyceridemia, augmented fasting glucose, and stroke incidence in those
subjects that are homozygous for the T-allele of the above-mentioned polymorphism. Their results
suggest that the adherence to the Mediterranean diet might attenuate the effect of this genetic
predisposition [26].
Ortega Azurim et al. found an association between the rs3812316 polymorphism at the MLXIPL
gene (MLX interacting protein like) with reduced circulating triglycerides levels and they reported
that the Mediterranean diet modifies the triglycerides (TG) concentrations. The protective effects of
the Mediterranean diet against cardiovascular risk were mainly evidenced in subject who presented
higher adherence to this dietary approach. In particular this study pointed out that the reduction
of cardiovascular risk, which was related to the adherence to Mediterranean diet, was especially
accentuated in carriers of the G-allele at MLXIPL locus [27].
Telomere length is modernly considered a marker of biological age and its involvement in
gene-diet interaction has recently been described. Other studies, in particular observational and ex
vivo works, have reported that a long-term adherence to Mediterranean diet seems to be related to
higher telomere length, activity. For example, Garcia Calzon et al. reported longer telomeres in women
joining Mediterranean dietary approach, but not in males.
Further analysis suggests that some gene variants might play a role in modulating telomere length
following Mediterranean diet approach; for instance, it has been considered Pro/Ala polymorphisms
of the peroxisome proliferator activated receptor γ2. It seemed that the carriers of Ala variant had
longer telomeres. Other observations were improvement in obesity parameters, dietary inflammatory
markers; these modifications probably lead to a slowed down process of shortening of telomere [28–31].
A group of 521 subjects from the PREDIMED study has undergone genetic analysis in order to
evaluate the expression of Ala allele in rs1801282 of PPARγ2 gene (peroxisome proliferator activated
receptor γ2). After a five-year follow up, it was observed that subjects following a constant strict
adherence to the Mediterranean Diet showed benefits because of their longer telomeres. The detection of
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an interaction between gene and diets could represent a further element that highlights the importance
of personalized dietary approaches in order to favour healthy aging [32].
The circadian locomotor output cycles kaput gene (CLOCK gene) has been recently studied by
Garcia Ros and colleagues in order to give data regarding the hypothesis that the habitual adherence to a
healthy dietary pattern as Mediterranean diet seem positively influence glucose metabolism; this effect
appeared to be mediated by interaction with the rs1801260 SNP in the CLOCK gene. Another study by
Lopez Guimera et al. investigated the interaction of CLOCK 3111T/C polymorphism in the response of
weight loss program; the authors found that this polymorphism seemed to have effects on emotional
eating behaviour thus influencing weight loss. In the light of these results, genetic predisposition
and higher exposure to Mediterranean diet impact on several traits, such as lipid profile, glucose
metabolism, emotional eating behaviour, and telomere length [33,34].
2.2. Role of Epigenome
In the context of gene-diet interaction, it is placed epigenetics, a fascinating area of research
that in the future might allow for understanding the molecular basis of this interaction, and thus to
predicting the risk of development disease and help to define prevention strategies and therapeutic
approaches. Epigenetic studies the changes in the genome might cause alterations in gene expression
without determining modification in the DNA sequence. Epigenetic mechanisms include noncoding
RNA function, DNA methylation, and histone modifications [8]. Diet may produce epigenome
changes, for example some nutrients constitute methyl donating components, as methionine, folic
acid, B vitamins, choline. The first impact of nutrients and their eventual imbalance presents effects
since foetal life; in fact, studies conducted on animal models but also human studies suggest that
an altered supply of nutrients during gestational periods, infancy is associated with a major risk of
mortality for cardiovascular diseases. Both excess and deficiencies of some dietary components might
induce epigenetic alterations that thus result inherited and influence phenotype. In this connection,
previous studies [35,36] reported a significant evidence of a relationship of maternal nutrient deficiency
and epigenetic perturbation leading to a higher cardiovascular risk and an augmented risk of
development chronic disease. An animal model pointed out that female offspring (APOE +/-) presented
a high susceptibility to form neointima after exposition to maternal hypercholesterolemia (APOE-/-).
This observation was different to that reported in same offspring that was exposed to wild type mothers.
Fetal programming and the exposition to specific dietary pattern thus seem to modulate epigenomic
processes and histone methylation. Another study in similarity with previous observations reported
that APOE-/- mice, which were more susceptible to atherosclerosis, showed some alterations of DNA
methylation that favoured the development of atherosclerosis [37,38].
Accumulating data point out the intricate relationship existing between diet and specific food
component and epigenetic mechanisms. Epigenomic wide association studies are an interesting novel
field of research that might allow for defining the key role of epigenetics and its changes in the context
of the development of disease in response to diet and environmental factors. Since early phases of
life, nutritional intake may induce DNA modifications through epigenetic changes, thus influencing
susceptibility to develop disease [39,40].
Several studies have reported that microRNAs constitute, among other functions, regulators
of numerous processes as apoptosis, lipid metabolism, cell differentiation, and glucose metabolism.
microRNA act inducing the silencing of their target genes inhibiting mRNA [41].
Richardson et al. observed that the minor allele of the single nucleotide polymorphism rs 13702
in the 3′UTR of LPC8 (lipoprotein lipase) gene determined the disruption of the recognition site for
micro RNA410. This effect resulted in gain of function, and finally in reducing the plasma levels of
triglycerides. This study reports the molecular basis of some cardiovascular effects and that these
molecular mechanisms seem to involve miRNAs and different regulation pathways.
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2.3. Role of Nutrigenomics
Nutrigenomics or nutritional genomics is a science studying mechanisms by which diet and
its nutrients interact with genes, therefore it represents an approach for investigating the different
responses of subjects after the same dietary interventions. These differences are studied in several
fields: genetics, transcriptome, metabolome, and epigenetics [42].
The mechanisms through which nutrients could modulate gene expression could be a direct
binding to nuclear receptors or act indirectly modulating epigenetic effects. Microarrays and real time
reverse transcription PCR are modern techniques by which to study gene expression modification [43].
Nutrigenomic studies have reported the protective effects of Mediterranean diet on vascular
inflammation, thrombosis, and foam cell formation through a modulation of the expression of
pro-atherosclerotic genes, also, the content of antioxidants represents one of the elements that is
responsible of the benefits of Mediterranean diet.
Konstatinidou’s study suggests that both Mediterranean diet and olive oil induce gene expression
changes if constantly taken [44].
Vazquez and colleagues analysed the metabolomics pattern of non-diabetic subjects participating
to PREDIMED study. They assigned the participants to two groups: low fat diet and Mediterranean
diet; they studied their urinary metabolomic profile with proton nuclear magnetic resonance.
The main hallmarks detected in the second group were 3 hydroxybutyrate, citrate, cisaconitate
that are related to carbohydrates metabolism, proline, glycine, N-acetylglutamine branched chain
amino acids that are related to the metabolism of amino acids, creatine, oleic, and subenic acids,
derived from lipids, and finally microbial cometabolites as p-cresol phenyl aceteylglutamine. Moreover,
they studied the metabolomics pattern that was related to walnut intake; this was studied through
high-performance liquid chromatography–quadrupole-time of flight mass spectrometry (HPLC-Q
TOF-MS). 18 metabolites were identified in that group undergoing dietary pattern enriched with walnut:
they include allagitannin, derived microbial compounds, metabolites of the tryptophan/serotonin
pathway, of fatty acid metabolism [45].
Gonzalez Guardia et al. studied the metabolomic profile of a group of elderly subjects that
were assigned to Mediterranean diet supplemented with Coenzyme Q10 (CoQ10). They reported
higher hippurate urine concentrations after four weeks of exposure to Mediterranean diet+ CoQ10;
on the other hand, in the group following a saturated fat diet, they observed increased levels of
phenylacetylglycine. This study suggests that long term exposure to a Mediterranean dietary approach
rich in CoQ10 is associated to beneficial effects on healthy aging and prevent mechanisms of chronic
oxidative stress.
The above-mentioned studies and other literature evidences show how nutrigenomics trough the
knowledge of the processes driving gene-diet interaction, but also of metabolic processes, could finally
provide individualized and accurate recommendations to prevent the development of several diseases.
2.4. Role of Microbiota
Mediterranean foods also have an impact on gut microbiota that, during the last few years, has been
identified as a possible risk factor of cardiovascular disease representing a potential therapeutic target;
so, microbiome could represent a possible intermediate of the effects of the Mediterranean diet of
modulation of cardiovascular risk factors [46,47].
Microbioma is the study of host enteric microbial ecology; metabolomics studies the role of low
molecular weight metabolites in biological samples. New insights come from the deeping of these
fields of research, reporting the systemic effects of gut microbiota, which are direct through a direct
interaction between microbes and host and indirect through the production of de novo metabolites or
that derive from diet. It was already known the role of gut microbioma in nutrient metabolism, enteric
immunity, in the production of micronutrients.
Limited studies have investigated how a complete dietary pattern might affect the metabolomic
profile; instead, numerous studies have examined the effects of single specific dietary components
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on metabolome (low molecular weight metabolites). In this stimulating field, it is possible to place
the study of the effects of Mediterranean diet on cardiovascular outcomes through its effects on gut
microbiota [48].
Over recent years, increasing evidence suggests that microbiome mediates the effects of
Mediterranean diet on metabolic mechanisms involved in the development of chronic diseases,
in fact it is clear that food intake and some specific components modify enteric microbiota inducing
changes that may be responsible of some effects exerted by Mediterranean diet.
The discovery of new biomarkers is one of the latest goals of nutritional metabolomics to define a
personalized diet as possible preventive tool and for managing diseases.
Some studies have delineated the metabolomics profiles in several dietary patterns as low-fat
diet, low glycaemic index diet, the New Nordic diet, very low carbohydrates diets, on the other hands,
currently there is little evidence regarding the metabolomics profiles in Mediterranean diet and their
association with the state of health.
Gonzalez-Guardia et al. conducted a crossover study in which they examined some biomarkers
in four groups of subjects following an isocaloric dietary pattern: the Mediterranean diet,
the Mediterranean diet supplemented with CoQ (Coenzyme Q10), the Western diet that is rich
in saturated fat, a low fat, high carbohydrate diet rich in n-3 polyunsaturated fat. In the second
group, they found higher urinary concentrations of hippurate and in the Western diet group they
reported higher levels of phenylacetylglycine in female participants. The greater levels of hippurate
showed a positive correlation with a circulating concentration of CoQ and ββ carotene and a negative
correlation with the genetic expression of superoxide dismutase 1, thioredoxin, transcription factor
Nrf2, the gp91phox subunit of nicotinamide adenine dinucleotide phosphate oxidase gene [49].
Kakkoura et al. investigated the effects of the interplay of some polymorphisms with the
Mediterranean diet on the serum levels of fourteen metabolites that were selected for their role
in influencing the expression of gene encoding enzymatic proteins that are modulated by specific
known polymorphisms. A higher adherence to Mediterranean approach was associated with an
increased MTHF [50]. Another cross-sectional study reported urinary microbial metabolites in
particular phenylacetylglutamine, p-cresol, 4 hydroxyphenylacetate were linked to a greater adherence
to Mediterranean diet [51].
As regards the Mediterranean diet, several studies have recently evaluated the metabolites in
the PREDIMED trial; metabolites that were assessed include ceramides, tryptophan, acylcarnitine,
glutamine, choline pathway metabolites. In particular, an increased cardiovascular risk has been
documented in the presence of elevated levels of choline pathway metabolites, ceramides, glutamine,
short chain triacylglycerol, monoacylglicerol, and acylcarnitines [52–57]. Meanwhile, a reduced risk of
cardiovascular disease has been reported in presence of greater cholesterol esters, polyunsaturated
phosphatidylcholines, and a major glutamine/glutamate ratio. The Mediterranean diet exerts a
protective role in the field of cardiovascular disease counteracting the harmful effects of such metabolites,
this association appear more relevant when baseline metabolites are evaluated.
However, a large variability in the metabolomic profiles of Mediterranean pattern emerges from
these studies, the difference and sometimes the conflicting results might derive from different biological
samples, the analytical methods, the study design, and the Mediterranean diet composition. In the
future, it is desirable to abolish the above-mentioned diversities standardizing methods.
Many nutrients, particularly protein and insoluble fiber, as evidenced by numerous metagenomic
data, have a strong impact on gut microbiota function, structure, and production of metabolic substances
that are able in modulation of the immune response and in the activation of many metabolic and
inflammatory pathways [56,57]. In fact, the restricted content of cholin and I-carnitine (substances
abundant in red meat, eggs, and cheese), as compared to other dietary regimen, leads to a reduced
cardiovascular risk: high levels of TMAO (trimethylamine N-oxide), product of the metabolism of
choline and I-carnitine, determine an increase of vascular inflammation and a direct prothrombotic
effect by the promotion of platelet hyper-responsiveness to multiple agonist both in humans and rodents,
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and these are probably associated to the pathogenesis of obesity and type 2 diabetes. High levels of
TMAO are associated to an increased risk of developing cardiovascular disease in both humans and
mice, regardless of risk factor [58,59].
Bacteroidetes (in particular, Bacteroides acidifaciens) have an important role in gut microbiota
through the production of high levels of short-chain fatty acids, including acetate, propionate,
or butyrate, in fact many experimental animal data suggest that their high levels can discontinue the
progress of several inflammatory, autoimmune and allergic disease [60]. Some authors think that
some of these useful effects could be mediated by the binding to specific G-protein coupled receptors,
placed on enteroendocrine and immune cells. The importance of gut microbiota is also underlined by a
recent randomized clinical trial, which has demonstrated the reshape of gut microbiota in a population
of obese adhering to Mediterranean diet for two years, which leads to an increase of Bacteroides,
Prevotella, and Faecalibacterium genera, and most importantly of the Roseburia and Ruminococcus
genera and Parabacteroides distasonis and Faecalibacterium prausnitzii bacterial species, known for
their saccharolytic activity and the ability to convert carbohydrates in short-chain fatty acids [61].
Accumulating evidences suggest that poor diet in “microbiota-accessible carbohydrates” can result in
the extinction of specific bacterial lineages, which leads to the modification of maturation process and
the function of immune system, which causes an increased risk of developing metabolic, inflammatory,
allergic, and autoimmune disease [62,63], differently, the long term adherence to healthier plant-rich
diets, through the reprogramming of human gut microbial functions, can play an important role in
promoting health and longevity [64,65].
2.5. Effects on Inflammation Markers
Inflammation is a crucial element in the pathogenesis of endothelial dysfunction as well as
atherosclerosis [66]. Strictly inflammatory elements, such as cytokines and adhesion molecules
expressed at the level of endothelial cells, as well as white blood cells, play an important role from the
early stages of atherosclerosis, as they promote the recall of inflammatory cells that are present in the
circulation, thus contributing to the development of atheromatous plaque [67].
In this context, several clinical and epidemiological studies have been conducted suggesting how
the beneficial role of the Mediterranean diet in the control of the main risk factors for the development
of arteriosclerosis could be in explained part through an anti-inflammatory effect on the endothelial
side, as shown by an improvement in endothelial function that is associated with a reduction in the
status of inflammation following the adoption of a Mediterranean dietary model [68–71].
Equally important results were reported by Estruch, who showed, in a sub-study of the PREDIMED
trial [72], the effects of the Mediterranean diet enriched with virgin olive-oil (VOO) or nuts on 106
individuals with a high cardiovascular risk [69]. The results suggested that, in contrast to what was
evident after the adoption of a low-fat diet, Mediterranean diet (MD) with VOO supplement could play
its role by changing the plasma levels of protein C and Soluble vascular cellular adhesion molecule-1
(sVCAM-1), as shown by the results that were obtained. In addition, this author showed that MD
enriched with VOO or nuts were both associated with a significant reduction, after three months of
observation, of the plasma levels of IL-6 as well as the expression of CD49d, an adhesion molecule
that is expressed by circulating inflammatory cells in peripheral blood, which is essential for their
recruitment and levels of the CD40 ligand.
Other experimental and clinical studies have found a reduction in cellular expression of vascular
cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) associated with a
decrease in E-selectin expression by endothelial cells as a result of olive oil consumption [73]; similar
results were shown for plasma Soluble intercellular adhesion molecule-1 (sICAM-1), E-selectin, IL-6,
and finally CRP [68,70].
As suggested by Estruch, these results support the hypothesis that the benefits obtained from the
Mediterranean diet enriched with VOO or walnuts are partly associated with its anti-inflammatory
effects, as shown by the reduction of levels of inflammatory cellular and circulating molecules that
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have always played a key role in the development of one of the most important risk factors, such as
atherosclerosis. For such motivations, lifestyle changes that include the adoption of a dietary model,
such as MD, can play a key role in CVD prevention.
3. Effects of Mediterranean Diet on Cardiovascular Risk Factors
It is now known, thanks to numerous findings from several randomized controlled trials [74,75],
the Mediterranean style exerts positive effects on most of cardiovascular risk factors, such as body mass
index, waist circumference, blood lipids, blood pressure, inflammatory markers and adhesion molecules,
and diabetes; moreover, accumulating data report that these advantages of the Mediterranean diet are
maintained also in comparison of a low-fat diet. We would like to briefly present some of the latest
scientific evidence about the effects of Mediterranean diet on diabetes, hypertension, lipid profile,
and thus on atherosclerosis.
3.1. Mediterranean Diet and Diabetes
Several randomized clinical studies have shown that a Mediterranean-type diet, which is made up
of different kind of vegetable, results in a significant reduction in body weight, unlike high-glycemic
index foods belonging to a Western diet. In fact, a 5-month randomized trial showed that women
who practiced a Mediterranean diet achieved a weight reduction of about 4 kg. These patients also
reported a reduction in blood glucose, peptide C values, and fasting serum testosterone levels, insulin
reduction after glucose tolerance test, and a marked increase in serum levels of Insulin-like growth
factor-binding protein 1–2 (IGFBP-1, IGFBP-2) and growth hormone binding protein. This study,
besides an improvement in body weight and in metabolism, also showed a reduction in the risk of
developing breast cancer, although these data should be verified in further studies [76]. In relation to
this, it has been hypothesized that the Mediterranean dietary regime that is involved the production of
short chain fatty acids with a consequent increase in intestinal hormones (GLP-1 and PYY), which inhibit
gastric emptying inducing satiety [77].
It has also been hypothesized that the intake of foods with a low glycemic index and a low content
of branched-chain amino acids, as well as an increased intake of monounsaturated acids, might lead to
a reduction in insulin resistance and consequent hyperinsulinemia [78,79].
In this regard, a study that was conducted on rodents showed that reduced methionine intake led
to an improvement in the glucose profile and a reduction in the risk of obesity and hepatic steatosis. It is
also determined an increase in serum levels of FGF2 and adiponectin, with a reduction of plasma levels
of IGF-1, leptin and T4. The Mediterranean diet does not only include low intake of methionine, but also
of other essential amino acids (such as tryptophan, valine, leucine, and isoleucine), which would seem
to modulate the insulin sensitivity.
In recent years, several studies have suggested that dietary models with high MUFA content have
positive effects on diabetes [80]. In this context, several studies have been conducted, some of which on
subjects that were predisposed to insulin resistance [81,82] and others on healthy individuals [70,83],
which suggested that dietary Mono-Unsaturated Fatty Acids (MUFA) consumption was associated
with an optimization of both glycemic control and insulin sensitivity, contrary to food with saturated
fatty acids (SFA), which can negatively affect these variables [84], particularly in cellular elements,
such as smooth muscle cells [85].
For example, Lopez et al. conducted a study on 14 healthy men with an average age of 27 + /−
7 and BMI (in kg/m2) of 23.9 +/− 1.9 in 2008, which had a single-blind, randomized, within-subject
crossover design; the results of this study suggested that progressive replacement of SFA by MUFA
had an effect on the function of pancreas B cells and on insulin sensitivity, resulting in progressive
improvement of the same in the postprandial period [86].
Prior to the study conducted by Lopez et al., Vessby et al. in the KANWU study, a 2001 study that
was based on 162 healthy individuals who followed a dietary model rich in SFA or MUFA for three
months showed how the high-SFA diet was associated with worsening insulin sensitivity [83]. In this
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study, it was also shown, ensuring a daily consumption of fat that was equal to 37% of the total energy,
an 8.8% increase in sensitivity to this pancreatic hormone following a diet rich in MUFA instead of
SFA, which instead caused a 12.5% reduction in this hormone.
However, other studies have assessed whether high MUFA diets had different effects compared to
dietary models with a high Carbohydrate (CHO) portion, focusing attention on a possible improvement
in sensitivity to insulin to prevent the development of resistance to insulin, and therefore type 2
Mellitus Diabetes through specific changes in dietary habits.
For example, Garg conducted a meta-analysis in 1998 based on ten different studies comparing
the nutritional effects of different dietary models, in particular high-CHO and high-MUFA diets,
in patients with diabetes. A comparison of these two different dietary approaches showed that MUFA
consumption is associated with optimization of lipoprotein profile and glycemic control [87], results
that were subsequently confirmed by Ros in 2003 which reassessed the relationship between the
adoption of a dietary model with a high MUFA content and a glycemic control level in patients with
type 2 Mellitus Diabetes [88].
Paniagua et al., with a prospective study including eleven offspring of patients with obesity and
diabetes divided into three groups, each following three different dietary plans each lasting 28 days,
showed how, when compared to consuming a diet that was rich in carbohydrates or saturated fats,
the MUFA-enriched diet has positive effects on insulin-resistant subjects through an improvement of
Homeostasis model assessment for insulin resistance (HOMA-IR), a substitute for insulin sensitivity
and proinsulin levels. Another important result that emerged from this study was the increase in the
amount of HDL-C and GLP-1 associated with the lowering of glucose and insulin plasma concentrations
in the postprandial phase after a breakfast that was enriched with olive oil, contrary to what has been
shown following a high carbohydrate diet [82].
Other studies confirmed a positive relationship between MUFA consumption and metabolic
control when compared to high CHO and SFA diets. Due et al. conducted a randomized controlled trial
based on 20 men and 26 women, randomly divided into three groups with different diets, in order to
compare and evaluate the effect of diets that are enriched with fats and carbohydrates on carbohydrate
metabolism. This study revealed that, after six months, the MUFA-rich diet had positive metabolic
effects through an improvement in variables, such as fasting glycaemia, and insulin, reduced by 3%
and 9.4%, respectively, and insulin sensitivity, as suggested by the reduction of the homeostasis model
assessment of insulin resistance score of 12.1%. In contrast, the other two dietary approaches have
been associated with an increase in these three variables [81]. In addition, several studies have been
conducted over the years to compare these different food approaches in order to assess their nutritional
effects on healthy subjects, as shown by the results of these studies, there is no significant divergence
between the plasma levels of the main metabolic control markers in subjects who have adopted three
dietary plans with different macronutrient compositions [89,90] (See Table 1).
Table 1. Main studies about Mediterranean diet and its effects on diabetes.
Author and Year Brief Description Conclusions
Due, A. et al.
2008 [81]
46 nondiabetic, obese men (20) and
premenopausal women (26) randomly assigned to
1 of 3 diets:
(1) MUFA diet (n = 16): moderate in fat (35–45%
of energy) and high in monounsaturated
fatty acids (>20% of energy);
(2) LF diet (n = 18): low-fat diet (20–30%
of energy)
(3) control diet (n = 12)
A diet high in monounsaturated fat has
a more favourable effect on glucose
homeostasis than does the typical
Western diet in the short term and may
also be more beneficial than the official
recommended low-fat diet during a
period of weight regain subsequent to
weight loss.
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Table 1. Cont.
Author and Year Brief Description Conclusions
Paniagua, J.A.
et al. 2007 [82]
A prospective study performed in eleven (7 W,
4M) offspring of obese and type 2 diabetes
patients randomly divided into three groups and
underwent three dietary periods each of 28 days
in a crossover design:
(a) diet high in saturated fat (SAT)
(b) diet rich in monounsaturated fat (MUFA;
Mediterranean diet)
(c) diet rich in carbohydrate (CHO)
Weight maintenance with a MUFA- rich
diet improves HOMA-ir and fasting
proinsulin levels in insulin- resistant
subjects. Ingestion of a virgin olive
oil-based breakfast decreased
postprandial glucose and insulin conc
entrations, and increased HDL-C and
GLP-1 concentrations as compared with
CHO-rich diet
Shah, M. et al.
2007 [91]
Test meals rich in palmitic acid, linoleic acid, oleic
acid, and eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) and containing
1000 kcal each were administered in a randomized
crossover design to 11 type 2 diabetic subjects
In comparison with palmitic acid and
linoleic acid, oleic acid or EPA and DHA
may modestly lower insulin response in
patients with type 2 diabetes without
deteriorating the glucose response. EPA
and DHA may also reduce the
triglyceride response
Perez-Jimenez, F.
et al. 2001 [92]
Intervention dietary study with a saturated fat
phase and two randomized-crossover dietary
periods: a high-carbohydrate diet and a
Mediterranean diet for 28 days each
Isocaloric substitution of carbohydrates
and monounsaturated fatty acids for
saturated fatty acids improved insulin
sensitivity in vivo and in vitro, with an
increase in glucose disposal. Both diets
are an adequate alternatives for
improving glucose metabolism in
healthy young men and women.
Brehm, B.J. et al.
2009 [89]
Overweight/obese participants with type 2
diabetes (n = 124, age = 56.5 ± 0.8 years, BMI =
35.9 ± 0.3 kg/m2, and A1C = 7.3 ± 0.1%) were
randomly assigned to 1 year of a high-MUFA or
high-CHO diet
In individuals with type 2 diabetes,
high-MUFA diets are an alternative to
conventional lower-fat, high-CHO diets
with comparable beneficial effects on
body weight, body composition,
cardiovascular risk factors, and
glycemic control
Vessby, B. et al.
2001 [83]
The KANWU study included 162 healthy subjects
chosen at random to receive a controlled,
isoenergetic diet for 3 months containing either a
high proportion of saturated (SAFA diet) or
monounsaturated (MUFA diet) fatty acids. Within
each group there was a second assignment at
random to supplements with fish oil (3.6 g n-3
fatty acids/d) or placebo
A change of the proportions of dietary
fatty acids, decreasing saturated fatty
acid and increasing monounsaturated
fatty acid, improves insulin sensitivity
but has no effect on insulin secretion.
A beneficial impact of the fat quality on
insulin sensitivity is not seen in
individuals with a high fat intake
3.2. Mediterranean Diet and Hypertension
Hypertension is the most common cardiovascular disease, which is defined as the persistence of
systolic and/or diastolic blood pressure (BP) values ≥ 140 and 90 mmHg, respectively. Elevated blood
pressure causes pathological changes at the vascular and cardiac level. For this reason, hypertension is
one of the main risk factors for cardiovascular diseases and renal failure [93].
According to current guidelines for the treatment of hypertension that were published by the
European Society of Cardiology (ESC) and the European Society of Hypertension (ESH), based on
meta-analysis, reviews of randomised controlled studies, observational studies, and systematic reviews
of studies in adults, the development of hypertension can be prevented, in combination with a
reduction in cardiovascular risk, by implementing lifestyle changes [94]. In particular, salt restriction
and moderation of alcohol consumption in association with the high consumption of vegetables
and fruits have proven to be effective strategies for reducing blood pressure. Therefore, one of the
optimal dietary patterns for hypertension control is one that includes a high consumption of vegetables,
legumes, fruits, low-fat dairy products, cereals, fish, and olive oil associated with low consumption
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of red meat and foods containing saturated fatty acids [95,96]. The traditional Mediterranean diet
(TMD), which includes most of these foods, has been correlated with blood pressure (BP) reduction.
The large-scale, randomized and controlled clinical trials, such as the PREvención study with DIeta
MEDITERRÁNEA (PREDIMED), showed how the administration of TMD enriched with extra virgin
olive oil (EVOO) or nuts to patients at high risk of cardiovascular disease had effects on the primary
prevention of these diseases. In this study, lower BP values were shown in patients who received TMD
+ EVOO or TMD + nuts when compared to the control group [97].
Nissensohn et al. conducted a systematic review and meta-analysis to examine the benefits of MD,
which was compared with a low-fat diet, on both systolic and diastolic blood pressure [98]. In this
study, six controlled randomised trials were included and they evaluated, in more than 7000 subjects,
those that were the effects of a Mediterranean diet pattern after an intervention period of at least one
year. For example, Toledo et al., in a randomised controlled study in 2013 based on 7447 subjects with
high cardiovascular risk that has been included in this meta-analysis, they showed, after four years of
follow-up, a significant improvement in diastolic blood pressure in subjects who had been assigned
to the two groups promoting the Mediterranean diet that was enriched with extra virgin olive oil or
nuts compared to those who had been allocated in the control group, who had been instructed to
follow a low-fat diet [99]. In view of the results that were obtained with this meta-analysis, Nissensohn
et al. showed a significant reduction in both systolic and diastolic blood pressure in subjects with
normal blood pressure or mild hypertension, after consumption of a Mediterranean diet. In particular,
the researchers pointed out that the effects of the Mediterranean diet are more significant for systolic
blood pressure, although the statistical impact of the meta-analysis was influenced by the small number
of studies that were included.
One of the major organs that participates in the regulation of pressure homeostasis is the
endothelium. Endothelial cells are able to synthesize molecules, such as nitric oxide (NO) and
endothelin 1 (ET-1), substances with vasodilatory action and vasoconstrictor, respectively [100,101].
A lack of balance between the production of NO and that of ET-1 induces endothelial dysfunction [102].
Several studies have shown that the reduction in NO levels and the increase in ET-1 are both involved
in the pathogenesis and development of hypertension, in combination with modifications of the
expression of their receptors [103,104].
Storniolo et al., in a recent trial of 2015 that was based on ninety non-smokers women divided
in three groups with different dietary plans, they showed that the TMD that was enriched with
EVOO or nuts partly reduced BP in hypertensive women inducing changes in the plasma levels of
endothelial-derived factors, such as NO and ET-1, and regulating the expression of the receptor gene
for the ET-1 [105].
Another interesting result of this trial was a significant increase of NO metabolites concentration
in TMD + EVOO group, however the serum concentration of ET-1 was significantly lower in the TMD
+ nuts group; therefore, the results that were obtained in this study suggested that the NO levels were
modulated by the components of extra virgin olive oil while the levels of ET-1 were controlled by the
nutrients contained in the nuts.
In recent years, many studies have shown that an important contribution to the pathogenesis of
hypertension is given by the effective reduction of NO bioavailability.
Storniolo et al. showed that TMD + EVOO is associated with both an increase in eNOS levels,
with a consequent increase in NO release, and a reduction in the expression of the gene that codes for
the Caveolin-2 protein, according to the proposal by Konstantinidou et al. [106], who hypothesized
that the TMD that was supplemented with VOO (virgin olive-oil) had positive effects by regulating
the expression of genes that were related to cardiovascular risk. Caveolin-2 is a crucial element of the
inner surface of small invaginations of the plasma membrane, called caveolae, and it is involved in
various cellular processes, including the inhibition of eNOS. Therefore, olive-oil components could
partly reduce the BP by negatively regulating the expression of caveoline, with a consequent increase
in the bioavailability of NO [107].
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In the last years, a significant role on reducing the cardiovascular and cerebrovascular risk profile
has been given to the strict interaction gene-environment with a particular focus on dietary influences
on genes expression [108].
In 2013, Castaner et al. conducted a study on peripheral blood mononuclear cells (PBMNCs) by
using whole transcriptome microarray analysis on a subsample of 34 subject of the PREDIMED trial
with the aim to evaluate if the beneficial effects of TMD were referred to nutrigenomics influences [109].
In the particular case of arterial hypertension, the authors identified seven different molecular pathways
that were related to the disease, such as hypoxia, nitric oxide, eNOS, P2Y purigenic, cardiac hypertrophic
signalling, aldosterone, and renin-angiotensin. The effects of these pathways could be referred to
JUN gene downregulation that was observed in patients treated with a polyphenol-rich olive oil,
according to the proposal of Camargo et al. [110], which have hypothesized that the benefits that are
associated with a polyphenol-rich could be determined by the effect on AP-1 activation, which lies of
heterodimer c-JUNcFOS. In particular, Camargo et al., showed how the anti-inflammatory effects of the
polyphenol-rich olive oil components could be mediated by the modulation of the expression of certain
genes that took part in NF-kB/AP-1 signalling pathways. When also considering that NF-kB was able
to modulate the expression of iNOS [111], which was an enzymatic isoform expressed after stimulation
by inflammatory cytokines, the polyphenols contained in olive oil could exert their protective effect
both by inhibiting these inflammatory pathways and by improving endothelial function.
Moreno-Luna et al., in a double-blind randomized, crossover dietary intervention study of 2012,
after four months long follow up, they showed that polyphenols, which are important components
of EVOO, were able to reduce BP in young women in stage 1 of essential hypertension promoting
an increase in the bioavailability of NO [112]. In this trial it has been showed the consumption of
Polyphenol-rich olive oil was associated with an increasing of plasma levels of nitrites/nitrates and
with a reduction of ADMA, an endogenous substance that inhibits NO synthesis [113].
Moreover, Moreno-Luna et al., in their study, they revealed a reduction in the amounts of oxidative
stress and inflammation mediators, such as Oxidized low-density lipoprotein (ox-LDL) and C reactive
protein (CRP) levels, in association with the consumption of Polyphenol-rich olive oil.
The ox-LDL are able to activate the renin-angiotensin system, which in turn activates Lectin-like
oxidized low-density lipoprotein receptor-1 (LOX-1) that is a receptor for ox-LDL trough angiotensin II
type I receptor, thereby exacerbating oxidative stress [114]. CRP is known for being responsible for
endothelial dysfunction and the way in which it exercises its role is to negatively alter the stability and
the uncoupling of NO synthase mRNA, therefore CRP represents a ligand of Lectin-like oxidized LDL
receptor-1 (LOX-1), taking part both in inflammation and oxidative stress, which are strongly related
to the development and maintenance of hypertension [115,116].
Entotelin-1 is another molecule that performs a key role on endothelial dysfunction and so on
development of hypertension.
As noted above, Storniolo et al. [105] also documented a reduction in the serum levels of ET-1
in subjects that submit a Mediterranean diet regimen implemented with nuts. In association with
the reduction of ET-1 levels, the results of this study suggested that TMD is able to determine the
downregulation of receptors that mediate the contractile effect of ET-1, such as ETAR (endothelin A
receptor) and ETBR (endothelin B receptor), which are implicated in the pathogenesis of hypertension.
In this way, the benefit that is associated with nut consumption on BP could be mediated, in part,
through reduced expression of ETAR and ETBR on muscle and endothelial cells, respectively, and the
depletion of ET-1 levels.
One of the peculiarities of the Mediterranean diet is the consumption of olive oil, which is
characterized by the high ratio between the content of monounsaturated and saturated fatty acids.
Psaltopoulou et al. [117] conducted a general population study, including 20343 volunteers from Greece
aged between 20 and 86, who had previously been enrolled to participate in the EPIC study, a study that
had been conducted in 22 research centres in 10 different European countries. The aim of the EPIC study
was to assess the contribution of factors, such as dietary, environmental, biological, or lifestyle-related
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factors to the pathogenesis of chronic diseases, such as cancer [118,119]. Psaltopoulous et al. showed
that the adoption of the Mediterranean diet was inversely related to blood pressure values. In particular,
another interesting result of this general population study was the significant association between olive
consumption and changes in both the systemic and diastolic values of BP, contrary to another important
component of the Mediterranean diet, such as cereals, currently positively related to BP [120,121].
In accordance with these results, other studies have shown how the long-term consumption of high
amounts of virgin olive oil (VOO), thus characterized by high layers of monounsaturated fatty acids
(MUFA) with particular attention to oleic acid (OA) (70–80%), which is present in triglycerides, promotes
the lowering of BP, thus preventing the development of chronic high tensive levels [74,122–124] OA
(cis-18: 1n-9) can influence a key element of BP control, such as the adrenergic receptor, as demonstrated
by recent studies [125]; it has been suggested that this effect could be due to changes induced by fatty
acid, at the level of the structure of cell membranes. The lipid component of the membrane can also
be modified by 2-hydroxyoleic acid, which represents a structural analogue of the same OA; these
molecules are sufficient for regulating the same intracellular signal transduction pathways [126,127].
In confirmation of what has been described, Teres et al., in a study that was conducted in 2008,
emphasized that the antihypertensive properties of olive oil could partly be due to the high content
of OA. In fact, previous studies have mainly attributed to the minor components of olive oil, such
as alpha-tocopherol, polyphenols, and other phenolic compounds, the protective effect of one of the
fundamental and characteristic foods of MD [128–131].
Teli et al., when comparing the effects of VOO, triolein (TO), the preponderant constituent of VOO
(characterized by a TG with three molecules of OA) and OA on BP, they showed that OA, both free and
esterified, was in able to positively modify the amount of cis-MUFA in the membranes, influencing the
conformation of the cell membrane (2,3 di 8), contrary to elaidic acid (trans 18: 1n-9 isomer of OA) and
stearic (18: 0), a result that suggests that the structure of the molecule is important to have hypotensive
properties. By increasing the distance between the polar heads of membrane lipids [132,133] by
increasing the concentration of cis-MUFA, OA and structural analogues or precursors define what are
the site, the degree of activity, and the concentration of components of important signal transduction
pathways, with particular attention to the 2A/D-adrenoreceptor/G protein/adenylyl cyclase-cAMP/
PKA system [125]. In addition to favouring the expression of cAMP and PKA, whose activation is
positively associated with vasodilation, this study showed that the consumption of VOO, TO, and OA
induced a reduction in the concentration of proteins with vasoconstrictor action, which include the
three isoforms of alpha subunit of G proteins (Galfa i2, Galfa i3, Galfa q/11) and PLCbeta, with a
consequent reduction of inositol phosphate, diacylglycerol, and calcium [134]. Another important
beneficial effect that was supported by the results of the present study is that OA negatively influences
the concentration of these second messengers through a direct mechanism, inhibiting the synthesis of
diacylglycerol and inositol (1,4,5) triphosphate and interfering with the cascade of calcium-activated
intracellular signalling [135]. With these data, Teres et al. emphasized that the consumption of OA is
significantly associated with an improvement in vasodilation systems together with a reduction in the
vasoconstriction pathways (See Table 2).
Table 2. Main studies about mediterranean diet and its effects on hypertension.
Author and Journal Brief Description Conclusions
Toledo et al. 2013 [99]
The PREDIMED primary prevention trial is a
randomized, single-blinded, controlled trial
conducted in Spanish primary healthcare centers.
7447 men (aged 55 to 80 years) and women (aged
60 to 80 years) who had high risk for cardiovascular
disease were assigned to a control group or to one
of two Mediterranean diets. The control group
received education on following a low-fat diet,
while the groups on Mediterranean diets received
nutritional education and also free foods; either
extra virgin olive oil, or nuts.
Both the traditional Mediterranean diet
and a low-fat diet exerted beneficial
effects on BP and could be part of advice
to patients for controlling BP. However,
we found lower values of diastolic BP in
the two groups promoting the
Mediterranean diet with extra virgin
olive oil or with nuts than in the control
group.
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Table 2. Cont.
Author and Journal Brief Description Conclusions
Storniolo et al.
2017 [105]
Non-smoking women with moderate hypertension
were submitted for 1 year to interventions
promoting adherence to the TMD, one
supplemented with extra virgin olive oil (EVOO)
and the other with nuts versus a control low-fat
diet (30 participants/group). BP, NO, ET-1 and
related gene expression as well as oxidative stress
biomarkers were measured.
The changes in NO and ET-1 as well as
ET-1 receptors gene expression explain,
at least partially, the effect of EVOO or
nuts on lowering BP among
hypertensive women.
Nissensohn et al.
2016 [98]
Six trials (more than 7000 individuals) were
identified. Meta-analysis showed that
interventions aiming at adopting an MD pattern for
at least 1 year reduced both the systolic BP and
diastolic BP levels in individuals with normal BP or
mild hypertension.
A positive and significant association
was found between the MD and BP in
adults.
Moreno-Luna et al.
2012 [112]
Double-blind, randomized, crossover dietary-
intervention study. After a run-in period of 4
months (baseline values), two diets were used, one
with polyphenol-rich olive oil (∼30 mg/day), the
other with polyphenol-free olive oil. Each dietary
period lasted 2 months with a 4-week washout
between diets
The consumption of a diet containing
polyphenol-rich olive oil can decrease
BP and improve endothelial function in
young women with high-normal BP or
stage 1 essential hypertension.
Alonso et al.
2004 [122]
Prospective cohort study whose members are all
university graduates to assess the risk of
hypertension associated with olive oil
consumption.
In a Mediterranean population, we
found olive oil consumption to be
associated with a reduced risk of
hypertension only among men.
Psaltopoulou et al.
2004 [117]
Arterial blood pressure and several
sociodemographic, anthropometric, dietary,
physical activity, and clinical variables were
recorded at enrollment among participants in the
Greek arm of the European Prospective
Investigation into Cancer and Nutrition (EPIC)
study.
Adherence to the Mediterranean diet is
inversely associated with arterial blood
pressure, even though a beneficial
component of the Mediterranean diet
score-cereal intake-is positively
associated with arterial blood pressure.
Olive oil intake, per se, is inversely
associated with both systolic and
diastolic blood pressure.
3.3. Mediterranean Diet and Lipid Levels
Many studies, which were carried out both in the past and in the recent present, have proved how
an adherence to the Mediterranean diet is strongly related to a reduction in blood pressure values and
to a beneficial alteration in glycemic and lipid profile [74,117].
Atherosclerosis represents the primary cause of cardiovascular diseases [136], which is due
to the fact that cholesterol-rich lipoproteins and apolipoprotein B become oxidized in the arterial
subendothelial matrix and this process determines the production of pro-inflammatory molecules
which activate the endothelium itself. This process is also mediated by monocytes, which are recruited
from the bloodstream. Once reaching the site, these cells become foamy cells after having phagocytized
the oxidized LDL, contributing to the increase in the size of the plaque and to the chronicization of the
inflammatory process [137,138]. The therapeutic strategies that were chosen in the treatment of these
pathologies range from the medical approach to the lifestyle approach [138]. On this basis, various
substances, contained in many products of Mediterranean diet, have been analysed, as they seem to
cause healthy and protective effects in cardiovascular field.
The extra virgin olive oil, the omega-6 and omega-3 fatty acids taken with the consumption of
shelled fruit and plant sterols represent the main source of fatty acids taken with the Mediterranean
diet [139,140].
The increased consumption of water-soluble fibres (contained in fruit and beans) has shown,
in numerous randomized controlled studies, a significant reduction in plasma LDL cholesterol
concentrations (each gram involves a reduction of about 1.12 mg/L of LDL cholesterol) [141,142].
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Another induced effect is represented by a reduction in the reabsorption of cholesterol and bile
acids in the intestine, with consequent absorption in the liver.
A significant amount of α-tocopherol, carotenoids, oleuropein, and phytosterols are contained in
100 g of extra virgin olive oil. Furthermore, olechantal is contained in the newly pressed extra virgin
olive oil; this phytosterol seems to inhibit COX activity, such as ibuprofen [129]. The dose that was
contained in 50 g of extra virgin olive oil does not seem to have powerful anti-inflammatory effects,
but it seems to guarantee protection against platelet aggregation.
A recent study by Allaire et al. [143] showed that the intake of DHA (docosahexaenoic acid),
compared to EPA (eicosapentaenoic acid), determined a significant reduction of CRP, TNF alpha,
IL 6, and triglycerides, with an increase in the concentrations of adiponectin and HDL cholesterol,
in subjects with high cardiovascular risk.
Carotenoids (a-carotene, b-carotene, lycopene, lutein, fucoxanthin, canthaxanthin, zeaxanthin,
b-criptoxanthin, capsorubin, and astaxanthin), which are mainly found in fruits and vegetables [144],
have antioxidant effects and they are involved in the regulation of the immune system and in the
transduction of messages within the cell [145,146]. Carotenoids are also implicated in the atherosclerotic
process that causes a slow of progression of atherosclerotic plaque [147,148]. A study that was conducted
by Cheng et al. [136] showed that the intake of tomatoes (rich in carotenoids) contributed to a reduction
in plasma LDL cholesterol concentrations.
Mozos et al., in their review, showed that, among carotenoids, lycopene, which is a bright red
carotenoid hydrocarbon found in tomatoes and other red fruits and vegetables, such as red carrots,
watermelons, gac melons, and papayas, is one of the most relevant because of its beneficial effect, such as
antiatherosclerotic, antioxidant, anti-inflammatory, antihypertensive, antiplatelet, anti-apoptotic,
and protective endothelial effects, the ability to improve the metabolic profile, and reduce arterial
stiffness [149]. However future studies are needed to better understand the mechanisms through
which lycopene exerts its favourable actions on pathogenesis of cardiovascular disease.
Phytosterols cannot be produced directly by humans, so it is necessary to assume them with diet.
Foods that are rich in phytosterols are vegetable oils, some cereals, but above all nuts [150,151]. Gylling
H et al. [152] showed that the intake of 2 g/day of phytosterols contributed to reducing LDL cholesterol
by about 10%.
Nuts, fruits, and vegetables also contain another antioxidant substance: coenzyme Q [153].
This coenzyme is present at the mitochondrial level and shares some elements with the biosynthetic
pathway of cholesterol, such as mevalonate. Treatment with statins results in a reduction of this
coenzyme and this appears to be associated with an increased risk of developing cardiovascular disease,
therefore individuals receiving statin treatment might experience a reduction in CoQ10 levels [154,155].
Zhang et al. [156] showed, in a meta-analysis based on 15 studies, how the supplementation of
this coenzyme to medical therapy resulted in a better glycemic and lipid profile control in patients
with type 2 diabetes mellitus.
Ambring et al. [157] conducted a study that evaluated endothelial function in healthy patients with
high lipid levels who practiced a Mediterranean diet. The results showed that the concentrations of the
various lipid components were more diminished in individuals who had practiced a Mediterranean
diet when compared to those with a Swedish diet.
Hernáez et al. [158] demonstrated that the Mediterranean diet supplemented with extra virgin
olive oil, in people with high cardiovascular risk, promoted the five main functions fulfilled by HDL:
cholesterol eﬄux and metabolism, anti-oxidant, anti-inflammatory and vasodilatory effect.
The basic function of HDL is to guarantee the eﬄux of cholesterol from peripheral to liver cells,
where it is released for metabolization [159]; This action is inversely related to the risk of developing
cardiovascular diseases [159] and major coronary events [160]. Once cholesterol is internalized, HDLs
esterify it through the LCAT enzyme (Lecithin–cholesterol acyltransferase) [161]. This activity is
assessed while using the HDL cholesterol esterification index, which allows for evaluating the LCAT
activity. The authors of this study showed that a Mediterranean dietary pattern supplemented with
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extra virgin olive oil increased the concentration of esterified cholesterol. This positive effect is
probably due to the antioxidant properties contained in the healthy foods of the Mediterranean diet,
which protect the LCAT enzyme from oxidation, guaranteeing its normal functionality [162].
Another function that is performed by HDL is the antioxidant activity, which, contrasting LDL
oxidation, prevents the formation of atherosclerotic plaques) [163]. This effect is determined by the
action that was carried out by the enzyme PON1 (Serum paraoxonase/arylesterase) [164]. This enzyme
appears to be a predictive biomarker of cardiac events [165], although its activity is still being
studied in humans [166]. The study that was developed by Álvaro Hernáez et al. showed that the
Mediterranean diet determined an increase in the arylesterase activity performed by PON1. In addition,
the Mediterranean diet that was supplemented with extra virgin olive oil promotes the induction of
nitric oxide synthase at the endothelial level by HDL [158].
Endothelial homeostasis is also guaranteed by the eﬄux of ABCG1-dependent cholesterol that is
determined by HDL rich in sphingosine-1-phosphate [167].
Sphingosine represents a marker of degradation of ceramides, which are a product of sphingolipid
metabolism. A recent study [168] evidenced how the consumption of walnuts results in an increase
in sphingosine concentrations without causing changes in dihydroceramide concentrations (de novo
ceramides synthesis marker). These data support the hypothesis that us based on the concept that
the reduction of the total ceramide levels is caused by increasing their catabolism, due to their more
intense activity. The results of this study showed that the consumption of walnuts determined a
reduction of the small LDL levels, particles with a pro atherogenic power greater than the large
LDL [169]. This study also showed an increase in plasma concentrations of large HDL, whose levels
were inversely related to the risk of developing cardiovascular diseases [170]. In this regard, the FDA
has established that the consumption of a certain amount of walnuts (about 42.5 g / day) contributes to
the reduction of the risk of developing cardiovascular diseases [171]. Moreover, walnuts are very rich
in polyunsaturated fatty acids (PUFA), primarily alpha-linolenic acid (ALA), an omega-3 fatty acid
with anti-atherogenic effects [172].
A recent study [173] was designed randomizing patients with a low-moderate cardiovascular
profile in two arms: the first, which was assigned a Mediterranean dietary regimen and the second
a low-calorie dietary regimen. The results that were obtained did not show significant changes in
terms of BMI and blood pressure, except for a reduction in the concentration of IL-17 induced by the
Mediterranean diet.
Furthermore, a study that was conducted on people who had followed a Mediterranean diet [174]
and subjects with a low-fat dietary regimen revealed how the first diet determined a reduction of
hepatic fat content (HFC) and visceral adipose tissue (VAT). This reduction in HFC was greater in
patients with Mediterranean diet as well as healthy effects. The results of this study evidence how the
reduction of hepatic fat content could play an important role on determining the beneficial effect by a
Mediterranean dietary regimen, even more consistently than visceral adipose tissue.
Another study [175] evaluated the relationship between a major cardiovascular event (acute
myocardial infarction) and other cardiovascular risk factors in southern European patients undergoing
a Mediterranean dietary regime. These results showed that the intake of carbohydrates and saturated
fatty acids was directly related with BMI increase in men but not in women, whose BMI changes were
associated to protein intake instead. They also evidenced that, in men, the plasma HDL-C concentration
was inversely related to BMI.
A sub-study [176] of the Attica study that was conducted on overweight and obese people showed
that increased insulin sensitivity and a better dietary profile were achieved in those subjects with
greater adherence to a Mediterranean diet.
Effects on Plasma Ceramides
Ceramides are precursors of complex sphingolipids. Some cellular and animal models reported
the pathogenetic role of the accumulation of ceramides in the activation of several signalling targets
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that impair normal cellular functions that also involve insulin action. Furthermore, this issue also
seems to be related to an increased de novo ceramide biosynthesis in response to cellular stress stimuli,
such as the exposure to saturated free fatty acids (FFAs) [169].
Ceramide and its metabolites have been reported as an intermediate point between excessive
feeding and metabolic abnormalities that cause cardiometabolic disease risk, such as insulin resistance
and low-grade inflammation [177,178].
However, to date, available evidence about ceramides and health outcomes mostly comes
from in vitro experiments and animal studies, and it is mainly based on intermediate outcomes of
cardiovascular risk.
Few studies have prospectively investigated the association between ceramides and the incidence
of cardiovascular and cerebrovascular events.
A recent study [179] analysed the relationship between ceramides and major adverse cardiovascular
events (MACEs) among apparently healthy individuals. Havulinna et al. quantified four circulating
ceramides, Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/24:0), and Cer (d18:1/24:1), in 8101 serum samples
by a targeted liquid chromatography-tandem mass spectrometry assay. Authors observed the strongest
association with incident MACE and the highest unadjusted hazard ratio of 1.31 (95% confidence
interval, 1.21–1.41) for Cer(d18:1/18:0), which remained significant at 1.21 (95% confidence interval,
1.11–1.33) after Framingham risk factor adjustments. The conclusion of this study was that distinct
serum ceramides were associated with the risk of incident of major adverse cardiovascular events
in apparently healthy individuals. These results suggest the role of ceramides in cardiovascular
pathobiology and suggest their role as possible new biomarkers of MACE risk.
Another recent study [180] measured six previously identified high-risk plasma ceramide molecules
[Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/20:0), Cer(d18:1/22:0), Cer(d18:1/24:0), and Cer(d18:1/24:1)]
in 167 consecutive patients with established or suspected Coronary Artery Disease (CAD) who
underwent either exercise or dypiridamole myocardial perfusion scintigraphy (MPS) for various
clinical indications. After adjustment for age, sex, smoking, dyslipidaemia, hypertension, diabetes,
prior history of CAD, left ventricular ejection fraction, and type of stress, testing were independently
associated with the presence of inducible myocardial ischemia. Thus, this study showed how
plasma ceramides are positive and independent predictors of stress-induced myocardial perfusion
defects in patients with established or suspected CAD referred for clinically indicated myocardial
perfusion scintigraphy.
Recently, Laaksonen et al. reported an unclear relationship between plasma ceramides CV events
underlying the role of two ceramides as the strongest predictor of CV events among patients with
coronary artery disease.
Wang et al. [54] evaluated participants from the PREDIMED trial (Prevención con Dieta
Mediterránea), including 230 incident cases of CVD and 787 randomly selected participants at
baseline (including 37 overlapping cases) followed for ≤7.4 years. The participants were randomized
to a Mediterranean diet supplemented with extra virgin olive oil, a Mediterranean diet supplemented
with nuts, or a control diet. In this study, the ceramide score, which was calculated as a weighted sum
of concentrations of four ceramides, was associated with a 2.18-fold higher risk of CVD across extreme
quartiles. Participants with a higher ceramide score and assigned to either of the 2 active intervention
arms of the trial showed similar CVD risk to those with a lower ceramide score, whereas participants
with a higher ceramide score and assigned to the control arm presented significantly higher CVD
risk. These findings suggest a positive association between the baseline plasma ceramide levels and
cardiovascular events and they report how adherence to a Mediterranean diet style may influence the
potential negative relationship between elevated plasma ceramide concentrations and CVD.
3.4. Effects of Mediterranean on Atherosclerosis
Cardiovascular diseases, which include coronary artery disease, cerebrovascular diseases,
peripheral artery diseases, and heart failure, constitute the main cause of mortality worldwide. WHO
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(World heart organization) estimates that cardiovascular disease will cause the death of 23.6 million
people by the year 2030. Atherosclerosis is the foremost cause of cardiovascular disease, especially
coronary artery disease and stroke; its risk factors include metabolic factors, genetic predisposition,
environmental factors, and behavioural habits [8].
Current knowledge highlights the key preventive role of the Mediterranean diet in the context of
cardiovascular disease; in this regard, in the last decades, several studies and some randomized dietary
intervention trials as the Lyon diet heart study have reported the beneficial effects of Mediterranean
style on the secondary prevention of the cardiovascular diseases. The PREDIMED study constitutes
the first randomized controlled and large-scale intervention trial that shows the significant impact
of the Mediterranean diet as primary prevention tool against cardiovascular events, such as stroke,
atrial fibrillation, peripheral vascular disease, and myocardial infarction [181,182]. Subsequently,
the PREDIMED trial reported that the adherence to Mediterranean diet enriched with EVOO or nuts
was associated with a reduction of 30% of cardiovascular events as compared with those reported in a
control group following a low-fat diet; the population of PREDIMED was high risk primary prevention
one [183].
Atherosclerosis represents the cause of almost 90% of cases of acute coronary syndrome, 60% of
strokes, the majority of case of chronic heart failure, peripheral arterial disease, and vascular dementia.
Hypercholesterolemia constitutes one of the fundamental risk factors of atherosclerosis. Numerous
studies have reported that decreased intake of saturated fat is associated with lower levels of plasma
cholesterol and lesser incidence of coronary heart disease; this relationship has been observed,
in particular, when saturated fat is substituted with polyunsaturated and monounsaturated fat.
The substitution of 5% of energy intake from saturated fats from the same quantity of energy from
polyunsaturated fats, monounsaturated fats, or carbohydrates from whole grains, is correlated to 25%,
15%, and 9% reduced risk of coronaropathy, respectively; instead, substituting saturated fats with
carbohydrates from refined grains is linked to raised risk of coronary heart disease. These observations
have been confirmed by various randomized controlled clinical trials that have shown a reduction of
approximately 30% of cardiovascular disease incidence when dietary saturated fats are replaced with
vegetable polyunsaturated fats. This percentage reduction is comparable to that induced by statin
therapy. A better and lasting cardiovascular benefit could be obtained if plasmatic cholesterol would
be maintained lower throughout life, promoting the prevention of atherosclerosis.
The traditional Mediterranean diet is characterized by a low consumption of meat, milk, and butter,
so the intake of saturated fats is almost 8% of energy, on the other hand, a higher intake of total fat
derives from extra virgin olive oil, various types of nuts, seeds, the germ of whole grains, constituting
25% to 35% of calories. Prospective studies have reported that the consumption of five servings of
nuts per week leads to a 40% to 60% reduction of coronary heart disease events. A great contribution
in reducing LDL-cholesterol and cardiovascular risk is given by nuts, especially almonds, hazelnuts,
walnuts, and pine nuts, which are a rich source of omega 6 and omega-3 fatty acids. A high intake of
water soluble fiber, of which a traditional Mediterranean diet is rich and which are found in beans
and fruits, is associated, as reported in some randomized controlled studies, with a relevant plasma
cholesterol lowering; according to some hypothesis water soluble fiber causes a decreased reabsorption
of cholesterol and bile acids in the small intestine, leading to increased LDL uptake by the liver [142].
The traditional Mediterranean diet includes very low amount of partially hydrogenated trans
fatty acids that are involved in the pathogenesis of coronaropathy. Replacing calories from mono
or polyunsaturated fat with trans fatty acids is associated with increased LDL cholesterol levels,
apolipoprotein B, triglycerides, lipoprotein, and reduced plasma levels of high-density lipoprotein
cholesterol and apolipoprotein A 1.
The first step in the management of hypertension, which is one on the main risk factors of
atherosclerosis, requires, among first steps, to follow an healthy diet, as the Mediterranean diet that
includes foods rich in vegetables, fruits is a resource of phytochemicals: it is known that these latter
show an inverse association to hypercholesterolemia and hypertension [3].
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A recent study by Shafqat and colleagues investigated the effects of Mediterranean dietary
pattern on a population of healthy US women with long term follow up, in particular they analysed
40 biomarkers that are involved in glucose metabolism, lipid metabolism, inflammation, branched
chain amino acids, and apolipoproteins. Moreover, the authors aimed to characterize novel factors that
could contribute to the relationship between Mediterranean diet and risk reduction in cardiovascular
events; the results of this study support the role of higher Mediterranean diet intake as preventive
tool of cardiovascular disease, even in non-Mediterranean diet populations. The positive effects
of Mediterranean diet that were described in this study might be partly explained by traditional
risk factors and novel risk factors. The main contribution of this reduction is due to the effects on
inflammation, followed by the effects on glucose metabolism, insulin resistance, blood pressure,
HDL, VLDL metabolism, although a minor contribution has been reported on LDL size and particles.
However, additional unevaluated factors might participate to this association [7].
Estruch et al. reported that the adherence to Mediterranean diet might improve anti-inflammatory
profile at a circulating and cellular levels; another study by Esposito showed that, after two-year
follow-up of exposure to Mediterranean diet, this dietary pattern was associated with an improvement
in hsCRP concentrations and endothelial function. In the light of these findings, the attenuation
of the inflammatory processes represents a mechanism mediating some of the beneficial effects of
Mediterranean dietetic regimen on cardiovascular diseases.
3.4.1. Role of Oxidative Stress
In the pathogenesis of cardiovascular diseases, oxidative stress plays a central role, with the
consequent formation of atherosclerotic plaques due to the increase in concentrations of oxidized LDL.
The low intake of anti-oxidants in the diet can indirectly increase the risk of acute heart disease in
apparently healthy people. The intake of β-carotene, vitamin C, vitamin E, natural folates, flavonoids,
and minerals (such as selenium), included in a Mediterranean diet regime. seems to contribute to the
reduction of this risk [184].
A significant reduction in circulating oxidized LDL and inflammation markers was achieved by
implementing a Mediterranean diet, as shown by a new randomized clinical trial [185,186].
The oxidative stress and the inflammation are both crucial points in the pathogenesis of endothelial
dysfunction, which contributes to the pathogenesis of atherosclerosis. Omega 3 fatty acids exert
their anti-inflammatory effect through binding to the 120 G protein-coupled receptor and inhibition
of inflammation NLRP3 [187,188]. Some phytochemicals contained in whole grains and in extra
virgin olive oil have an anti-inflammatory action. A lot of phytoprotectants, such us ferulic acid,
lignans, and phytic acid, are contained in aleuron layer of wheat bran, and they have antioxidative and
anti-inflammation properties [189,190].
The whole grain contains a spermidine (polyamine) that seems to extend the life of human
cells [191]. Histone acetyltransferases is inhibited by this polyamine and this causes a reduction
in inflammation, cellular necrosis processes typical of aging and, finally, a greater resistance to
oxidative stress.
Antioxidants compounds are richly represented in Mediterranean foods and seem to mediate
the major beneficial effects of the Mediterranean diet, other salient mechanisms through which
the Mediterranean diet exerts its central role in the context of the cardiovascular prevention are
anti-inflammatory effects, modification of the microbiota, the modulation of gene, and protein
expression [3]. Recently, a study by Kouli GM et al. [192] has showed that hydroxytyrosol exerts
mechanism of repair on oxidative damage and determines an improvement of circulating lipids.
This molecule is contained in fruits, nuts, legumes, and extra olive oil.
Some researchers observed a reduction of the circulating 8-hydroxy-2′deoxyguanosine (8-OHdG)
levels in individuals on Mediterranean diet when compared to those on SFAs rich diet; this study by
Urquiaga did not permit to define the exact contribute of a moderate intake of red wine because both
the diets include it [193].
Int. J. Mol. Sci. 2019, 20, 4716 24 of 47
8-OHdG is an oxidized nucleoside of DNA. It is frequently detected in nuclear and mitochondrial
DNA; as result of DNA repair, 8-OHdG is excreted in the urine. Numerous findings have reported
that urinary 8-OHdG not only is a biomarker of generalized, cellular oxidative stress, but it could also
be considered a risk factor for atherosclerosis, diabetes, and cancer. Some human studies described
increased amounts of oxidatively modified DNA and 8-OHdG in human atherosclerotic plaques.
Elevated urinary 8-OHdG were also detected in diabetic patients with hyperglycaemia; moreover,
it has been observed that its urinary concentrations in diabetes correlated with the severity of diabetic
complications (nephropathy, retinopathy) [194].
3.4.2. Effects of Mediterranean Diet on Foam Cells Formation
Florez et al. conducted a study that showed how the extra virgin olive oil rich in linoleic acid
induced a greater internalization of triacylglycerol in THP-1 macrophages, when compared to extra
virgin olive oil rich in oleic acid [195]. The results that were obtained from this study evidenced that the
different composition of fatty acids of extra virgin olive oil played an important role in the formation
of foam cells. Indeed, studies that were conducted on THP-1 macrophages showed that fatty acids that
are rich in oleic acid reduced the accumulation of lipids in macrophage cells. This would seem to be
due to a down-regulation of apolipoprotein B48 receptor [196]. On the other hand, linoleic acid would
seem to stimulate the CD36 receptor, leading to an accumulation of triacylglycerol in the cells [197].
CD36 is an important macrophage scavenger receptor that binds oxidized LDL [198]. Up-regulation
of the CD36 receptor appears to be due to both increased stimulation of transcriptional and
post-transcriptional mechanisms. Furthermore, it seems that PPARs play a role in this over-regulation by
promoting the transcription of this receptor, since fatty acids are ligands of PPARα and PPARγ [199,200].
Accordingly, the expression of this receptor seems to play a role in the formation of foam cells and fatty
acids would determine the regulation of gene expression [197].
3.5. Mediterranean Diet and Arterial Stiffness
Arterial stiffness is the ability of arteries to expand and contract in relation to the various
stages of the cardiac revolution, converting intermittent blood flow into a more stable flow, and it
can be considered as a potential factor in the beginning and progression of atherosclerosis as well
as hypertension.
Therefore, increased arterial stiffness could serve as an “early marker” for discovering initial
signs of atherosclerosis and/or arterial structural changes that are caused by various risk factors,
including hypertension.
Epidemiological longitudinal studies showed an independent predictive value of arterial stiffness,
the carotid pulse pressure, and the Augmentetion index (AIx), measured directly by a tonometer,
for cardiovascular events [201].
Most of the evidence was given for aortic stiffness, as measured through the carotid-femoral pulse
wave velocity (PWV).
In recent years, aortic stiffness has shown an independent predictive value for all causes of
cardiovascular mortality and mortality, fatal and non-fatal coronary events, and fatal strokes in
patients with uncomplicated high blood pressure, type 2 mellitus diabetes, and complicated kidney
alterations [202,203].
In the last few years, many studies evidenced a straight interaction between a dietary pattern rich
in vegetables (excluding potatoes), fruits, whole grains, nuts, legumes, fish, ratio of monounsaturated-
to-saturated fat, all components of the typical Mediterranean Diet, was associated with a reduction in
cardiovascular risk factor, and among these, even the arterial stiffness.
Van de Laar et al., in a longitudinal study of 373 patients observed between the ages of 13 to
36 years, tried to investigate whether adherence to a Mediterranean dietary pattern during adolescence
and early adulthood affects arterial stiffness in adulthood. At the age of 36, individuals with higher
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carotid arteries stiffness had a less adherence to the Mediterranean Diet, defined by lower aMED scores,
underling the importance of a correct alimentation, especially in the early stages of growth [204].
Rodriguez Martin et al., in a sub-analysis of the EVIDENT study consisting of 1553 subjects
(aged 20–80 years) with no cardiovascular disease, evaluated the relationship between the EVIDENT
diet index (0–100), good predictor of adherence to Mediterranean Diet, and cardiovascular risk and
pulse wave velocity (PWV) of the sample. In the logistic regression analysis, adjusted for age, gender,
smoking, energy intake, antihypertensive, antidiabetic and lipid-lowering drugs, and systolic blood
pressure, it was shown that the increasing of the EVIDENT diet index was associated with a reduction
of the PWV and, consequently, with a reduction of the cardiovascular risk emphasizing the importance
of arterial stiffness as a predictor of CV event [205].
4. Mediterranean Diet and Coronary Artery Disease
Over the past decades, several studies reported that a strict adherence to Mediterranean diet
might prevent inflammation, which exerts a central role in the pathogenesis of atherosclerosis and
cardiovascular disease [69,206]. Further recent studies reported that better compliance with the
Mediterranean dietary pattern might, over time, down-regulate the development of atherosclerosis in
the coronary arteries [207,208].
A recent Turkish study reported the existence of a relationship between the extensiveness of
angiographic quantitative coronary artery disease (CAD) adherence to Mediterranean diet [209].
These findings suggest that a higher compliance with the MD leads to lower extensiveness of
CAD. To date, there are not sufficient data on highly probable association between Mediterranean
diet and severity of CAD, although this eating pattern has been widely studied in the context of
cardiovascular disease.
A recent study analysed the relationship between dietary patterns and a score evaluating coronary
morphology, the SYNTAX score, and in coronary artery disease (CAD) patients from the INTERCATH
study [210]. At logistic regression analysis, the strongest correlation with Mediterranean dietary pattern
was found for hs-RCP and this association remained significant after adjustment for cardiovascular
risk factors. These results suggest an independent association of adherence to Mediterranean diet
with less complex CAD. Moreover, in the light of these results, Hs-CRP might appear as a marker of
the vasoprotective effects of the Mediterranean diet. These results strengthen the evidence for the
protective effect of a MeDi pattern in cardiovascular prevention.
Acar et al. evaluated patients who had a history of coronary revascularization at least six months
before to enrolment [211]. An alternate MeDi score was calculated to evaluate the Mediterranean style
dietary adherence. By applying this measurement, after a multivariate analysis the authors concluded
that the adherence rate to a healthy diet was low in patients with previous coronary revascularisation.
The Seven Countries Study was the first to underline the differences in CAD mortality rates between
the 16-country cohort from northern to southern countries and also from Japan to the peculiar dietary
patterns of each country of the participants and, in particular, it showed the important role of the intake
of saturated fatty acids and flavonoids.
Investigators from the Lyon Heart Study [212] studied 605 patients aged 55–80 years with previous
CAD; the authors observed that a better cardiovascular risk profile of the Mediterranean diet also
extended to the clinical setting of the secondary prevention of cardiovascular disease. This study
showed that patients that strictly followed a Mediterranean diet style had 50–70% lower risk of
recurrent clinical events related to coronary artery disease.
These findings corroborate the role of the adherence to a Mediterranean dietary pattern as
compared with other diet styles, in the context of a so-called prevention Step–I (i.e., total fat <30% of
total calories, carbohydrates >55% of total calories, protein about 15% of total calories, and cholesterol
<300 mg/dL).
The CARDIO2000 investigators [213] conducted a study in which they analysed 848 middle-aged
and older patients with previous myocardial infarction and unstable angina and 1078 age- and sex-
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matched controls from Greece. They reported that a higher degree of adherence to a Mediterranean diet
was linked to a significant rate reduction (−23%) of the risk of developing a first ischemic cardiac event
and this coronary benefit was more significant in people who were living in rural areas as compared
with subjects living in urban or semi-rural areas.
The same scientific group also reported the synergistic effect of the combination of the
Mediterranean diet with statin treatment on coronary risk; in fact, they showed that the combination
approach of diet + statin was associated with a 43% reduction in coronary risk, independently from
cholesterol levels and other cardiovascular risk factors.
Recently, the PREDIMED study, a prospective study involving 22,043 adults from Greece [118],
reported that a 20% increase in the Mediterranean diet score was associated with a 33% reduction in
coronary heart disease mortality, thus highlighting the existence of a significant negative relationship
between a high adherence to the Mediterranean diet and death from coronary heart disease.
The results of this study were irrespective of sex, smoking status, level of education, BMI,
and physical activity, but strictly dependent from the age of patients with higher effects in patients
≥ 55 years, but not in those ≤ 55 years.
In the light of these findings, this study explains that a cultural adherence to Mediterranean diet,
just the simple recent adoption of a healthy dietary pattern, seems to be the only practical way of
heart protection.
What of the single elements of the Mediterranean diet have been reported to more strictly
linked to cardiovascular risk reduction is an unanswered question. The “Habits in Later Life Only”
study reported that only legumes intake was associated with a reduction in mortality hazard ratio,
after adjustment for location/ethnicity of the analysed elderly people from Japan, Sweden, Australia,
and Greece. Nevertheless, Dontas et al. [173] found that higher adherence to the Mediterranean diet
was associated with 21% lower odds of being affected by one additional risk factor (i.e., hypertension,
hypercholesterolemia, diabetes, and obesity) in women and with 14% lower odds in men, irrespective
of various potential confounders. This observation could be directly related to the reduction of
cardiovascular risk, and therefore to life extension.
5. Mediterranean Diet and Congestive Heart Failure
Heart failure (HF) is defined as a clinical syndrome that is secondary to the inability of the heart
to adapt the cardiac output to the metabolic needs of the organism or, in any case, to be able to do so
only at the expense of increasing the filling pressures in one or more chambers cardiac and venous
circulation upstream.
According to more recent epidemiological data, the prevalence of HF has increased in recent
years, by 1–2% in the adult population and by more than 10% in older subjects. The main risk factors
are hypertension, obesity, type 2 diabetes mellitus, and, in general, acute cardiovascular diseases
(CAD) [214]. The primary prevention for HF is currently one of the main public health battles. In recent
years, important evidence has emphasized as lifestyle changes, which include changes in the individual
dietary approach and play an important role in primary prevention for CVD [215].
As shown by the results of the PREDIMED Study, the Mediterranean diet (MD) is considered
to be an effective strategy for the primary prevention for the development of cardiovascular disease
(CVD), such as myocardial infarction and stroke [97].
Although this study was the first to suggest that Traditional Mediterranean diet (TMD) could
have benefits on the primary prevention of heart failure (HF), which is justified by the data obtained,
the effects on HF incidence in subjects who had adopted that dietary model was only a protocol-specified
secondary outcome of PREDIMED.
To our knowledge, the beneficial effects of effective dietary patterns, which outsource the
consumption of specific nutrients, on the primary prevention of HF have not been assessed by
systematic review or meta-analysis. For this reason, D’Almeida et al., in a recent review in 2018,
analysed five randomized controlled trials, seven court studies, and two cross-sectional studies, for a
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total of 188470 subjects, with the aim of defining the effects of six different dietary models on the
primary prevention of HF [215]. Among the dietary regimens that have been studied by these authors,
there are the Mediterranean diet (MD) and Dietary Approach to Stop Hypertension (DASH); the DASH
diet is one of the recommended dietary models, because it can influence blood pressure, which is
positively correlated with functional changes in the cardiac and endothelial levels [216,217]. D’Almeida
et al. have observed that HF could be prevented by adhering to one of these two types of dietary
patterns, although these data should be further studied and re-evaluated, according to the poor power
of the findings.
In the specific case of the MD, the authors included four randomized controlled trials and four
court studies in this systematic review. During the research of the various studies, one of the trials that
was identified and subsequently inserted aimed to analyse the incidence of HF. Papadaky et al. have
conducted a recent secondary analysis of the pre-specified outcome of the PREDIMED trial with the aim
of assessing whether TMD could influence the incidence of HF [218]. This study included 7403 subjects
with high cardiovascular risk divided in 3 groups with different dietary plans, with type 2 diabetes
mellitus and/or at least 3 other CVD risk factors including family history of premature coronary heart
disease, smoking, hypertension, low HDL-cholesterol levels, high LDL-cholesterol levels, or obesity
(body mass index ≥25 kg/m2). This study, based on 7403 subjects with high cardiovascular risk and
divided into three groups with different dietary models (TDM + EVOO, TMD + nuts and low-fat
control diet), showed no significant association between adoption of TDM enriched with EVOO or
nuts and no reduction of the incidence of HF. According to the observation of only 94 HF cases during
the trial, the authors hypothesized that the results of this secondary analysis of a pre-specified outcome
of the PREDIMED study were inconclusive due to the low power of the trial, in combination with
evidence that dietary patterns might influence HF development differently, depending on the type,
severity, and general etiopathogenesis of the syndrome [69,219].
The Mediterranean diet could partly change the incidence of HF due to the now known
anti-oxidative and anti-inflammatory properties that characterize most of the components of this
dietary model [220]. Several studies have shown that factors, such as oxidative stress [221] and
inflammation [222], play an important role in the pathogenesis of HF.
Fito et al. in 2014 conducted a sub-sample study of 930 subjects at high cardiovascular risk
previously enrolled in the PREDIMED study to show how adhesion to TDM could reduce the levels of
important biomarkers of HF with special attention to N-amino terminal fragment of the prohormone
BNP (NT-proBNP) [223]. These participants, who had not yet been diagnosed with CVD at the time of
enrolment, were randomly assigned to one of the three dietary intervention groups. The results of this
study showed that TMD lowers NT-proBNP levels as compared to the controlled diet, after one year
of intervention. Another important finding was a reduction in concentration of oxLDL and lp(a) in
participants that were assigned to the TMD + EVOO group. Therefore, the authors confirmed their
hypothesis of a protective effect of TMD by promoting changes in HF biomarker values.
Brain natriuretic peptide (BNP) is a hormone that is encoded by a gene whose transcription is
mainly induced by the stretching of the left ventricle wall in response to an increase in tensive values or
volume. The proBNP, which is a peptide of 108 amino acids, is subsequently cleared into BNP, a peptide
of 32 amino acids, and NT-proBNP, a peptide of 76 amino acids, biologically inert. NT-proBNP has
recently been defined as a sensitive marker and predictive factor of acute HF [224], with an important
prognostic meaning in this context [225].
Therefore, although cardiac wall stress is the main event that is responsible for releasing these
molecules, a wide range of factors and structural and functional abnormalities of the heart can trigger
an increase in BNP or NT-proBNP. In this context, among the factors that might influence the values of
these two peptides, there are counted interluchin 1β (IL-1β) and another important pro-inflammatory
cytokine as tumour necrosis factorα (TNFα), promoting the expression of the gene consideration [226];
the plasma concentration of TNFa and the expression of the IL1b gene have been associated with the
consumption of TMD [227,228].
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These observations were confirmed by data that were obtained by Fito et al., who showed a
correlation between TDM and reduction of oxidative stress damage and TNF receptor expression
(TNFR), in agreement with the study of Urpi-Sarda et al. [227], which observed how those who
improved their diet towards a model of MD, in particular the consumption of its specific components,
such as VOO and vegetables, reduced the conception of TNFR.
In recent years, an important role in promoting the development and progression of HF has been
attributed to oxidative stress, an expression that indicates an excessive increase in the relationship
between production and growth, by special systems, reactive oxygen species [229,230]. Mallat et al.,
observed increased levels of lipid peroxidase and 8-iso-prostaglandin F2alfa in patients with HF,
which are important markers dosed in blood and pericardial fluid; these data are in accordance with a
systematic review, published in the year 2011, which showed how optimizing ROS production could
take a more important role in promoting oxidative stress in HF than reducing the effectiveness of
antioxidant systems [221]. Mitochondria, NAD(P)H oxidase, xanthine oxidase are, together with nitric
oxide synthetase (NOS), the main spring of ROS within myocardiocytes. Within the framework of
these systems, special attention should be given to mitochondria, which physiologically produce
low amounts of ROS during cellular respiration; mitochondrial dysfunction is therefore significantly
associated with increased production of ROS, promoting oxidative stress [231]. The alteration of the
balance between the production and inactivation of ROS, which take place through various mechanisms
that include alterations to mitochondrial DNA (mtDNA), induces significant damage to mitochondria
that results in dysfunction and activation of a vicious circle, characterized by further production of
ROS and worsening of the mitochondrial dysfunction, which culminates in cellular damage [232].
Finally, the persistence of oxidative stress promotes the progression of HF by encouraging cardiac
remodelling; chronically elevated ROS levels activate several signal transduction pathways and
transcription factors that are involved in cardiac hypertrophy [233], induce apoptosis [234], and activate
metalloproteinase (MMPs), enzymes that are involved in tissue remodelling [235] and whose activity
was positively associated with HF, probably as a result of the ROS increase [236].
In this context, previous studies have suggested that the protective effect of MD on cardiovascular
risk is partly mediated by the anti-oxidative properties of important foods that characterize this dietary
model [237]. To our knowledge, the studies that were conducted with the aim of defining how MD
reduces oxidative stress are limited. For this reason, Dai et al., in a twin study that were conducted in
2008 and based on 297 twins (81 monozygotic and 57 dizygotic pairs of twins, nine monozygotes, and 12
dizygotes unpaired twin), studied the beneficial effects of MD on oxidative stress [220]. Establishing the
relationship between reduced glutathione (GSH) and oxidized glutathione (GSSG) as a plasma surrogate
for oxidative stress, the results of the present study suggested that the adoption of a Mediterranean
dietary model correlated with the increase in the GSH/GSSG ratio, consistently with the data obtained
from previous experimental studies on animals that have emphasized as typical components of MD
foods, such as polyphenols, favoured a reduction of the oxidative stress defined by the decrease in
the quantity of GSSG not associated with a change in the quantity of GSH [238,239]. The validity of
these results stays precisely in the study design, paying particular attention to the choice of a sample of
monozygotic and dizygotic twins belonging to the same family, which allowed for controlling genetic,
behavioural, and socioeconomic factors, defined as the unmeasured confounding factors.
The MD can determine the increase of GSH/GSSG through different mechanisms. When considering
that the GSSG, as obtained from the oxidation reaction of GSH catalysed by glutathione peroxidase [240],
is again converted into GSH thanks to the simultaneous oxidation of NADPH [241], MD can partly
reduce oxidative stress by increasing the availability of NADPH and the expression of glutathione
reductase [242], the enzyme that catalyses the second of the two reactions described above. In this
way, the decrease of GSSG, which results in an increase in the GSH/GSSG ratio, is mediated by the
effects of nutrients and other components that are contained in the typical foods of the Mediterranean
dietary pattern.
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The increase in this ratio can be attributed to the reduced consumption of glutathione as the main
antioxidant mechanism, since the MD is a dietary model that is enriched with other antioxidants as
well known, such as vitamin C, vitamin E, carotenoids, polyphenols, zinc, and selenium [243].
Resveratrol is a type of natural phenol, a stilbenoid that is contained in blueberries, the skin of
grapes, raspberries, and peanuts. Several studies have described its benefits. Yeung et al. analysed
numerous research publications on resveratrol investigating its effects on health. This work reported
and underlined the antioxidants activity, the antidiabetic, and antimicrobial properties of this phenol;
moreover, it described the role of resveratrol as mediator of anti-proliferative and anti-inflammatory
activities via gene expression alterations and metabolic pathway modulations [244].
In addiction it is potentially involved in the prevention and treatment of cardiovascular diseases,
cancer, neurodegeneration, obesity, and diabetes.
Among the predictors of morbidity and mortality in chronic HF, there are low-density oxidized
lipoprotein (oxLDL) plasma levels [245,246]. Fito et al. observed a reduction in oxLDL levels of
approximately 8 U/L in subjects who followed an MD model for one year. In addition, in 2008,
Bergmark et al. conducted a study that highlighted how oxidized phospholipids were transferred
from oxidized LDL predominantly to lipoprotein a (Lp(a)), which is an LDL molecule that is linked
to apolipoprotein (a) rich in carbohydrates (apo(a)) [247]. In the control group, an increase in Lp (a)
plasma levels was obtained, which was attributed to the increase in other lipoprotein plasma markers
rich in triacylglycerol (TRL) and in apolipoprotein (apo) CIII non-HDL [248]. In the TDM groups the
same results were not recorded, and even the TMD + VOO promoted a significant reduction in the
levels of LP (a) when compared with the control group. Fito et al. also found a reduction in TRLs after
TMD adoption [249], which confirmed what was previously hypothesized.
6. Mediterranean Diet and Stroke
The Seven Countries Study shows how the Mediterranean diet, followed by the population of
Crete, is the best in terms of prevention against stroke. This study reports that the coronary risk in
Finland is 15 times greater than that in Crete, which is 40% of that in Japan [250].
The Mediterranean diet is described by Ancel Keys as ‘a mainly vegetarian die favouring fruit
for dessert’. In fact, this diet provides for reduced glycemic intake with a fatty acid intake of 40%,
represented mainly by healthy fatty acids, which are associated with a higher consumption of fruit and
foods with a high fiber content.
In confirmation of this observation, a study that was conducted in India [251] showed how the
Mediterranean diet that was practiced for two years, as compared with a diet poor in fat, resulted in a
50% reduction of coronary and cerebrovascular events, although 60% of subjects had a vegetarian diet
at the time of enrolment.
A recent meta-analysis [252] indicated that an absolute adherence to the Mediterranean diet,
independently from the population analysed, defined a lower risk of stroke both ischemic and
haemorrhagic (about 16% for each four points higher in the MedDiet Score).
In fact, as shown by the results of the INTERSTROKE study, there is a considerable reduction in the
risk of stroke related to the diet practiced, in all of the different ethnic groups that were studied [253].
A multicentric randomized study was conducted in Spain [183], in which the participants (7447
enrolled patients) with a high risk of developing cardiovascular diseases were divided into three
arms: one that was given an indication to practice Mediterranean diet supplemented with extra
virgin olive oil, one that was given an indication to practice Mediterranean diet supplemented with
nuts, and, finally, a control group that was supposed to practice a hypo-caloric diet. The follow up
was three-monthly and each participant received the amount of oil or nuts that he would have to
consume. The number of major cardiovascular events represented the primary endpoint. These events
occurred overall in 288 subjects of which 96 were part of the group that practiced a Mediterranean
diet supplemented with extra virgin olive oil (3.8%), 83 were part of the group that practiced a
Mediterranean diet supplemented with nuts (3.4%), and 109 belonged to the control group (4.4%).
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However the results obtained concerned the combined cardiovascular endpoint, represented by the
risk of developing cardiovascular and cerebrovascular events. Data from the PREDIMED trial are in
line with the results that were obtained from other observational studies, which have shown how
the Mediterranean diet has protective effects in the cardiovascular field [254,255]. In fact, in the
Three-City Study, it examined the correlation between the consumption of extra virgin olive oil/plasma
concentration of oleic acid and the incidence of stroke. The follow up was five years. The results
obtained, adjusted for socio-demographic, physical, and body mass index variables, and also for
individual risk factors for stroke, showed an inverse correlation between the incidence of stroke and
the consumption of extra virgin olive oil. Patients that consumed greater quantities of extra virgin
olive oil had a risk of stroke of 41% lower, as compared with participants that have never consumed
extra virgin olive oil.
According to the findings of several studies, the beneficial effects that were induced by
the Mediterranean diet are determined by its action towards the main risk factors for stroke,
such as inflammation, oxidative stress, endothelial dysfunction, platelet aggregation [256,257],
and diabetes [258].
The reduced consumption of saturated fatty acids, as demonstrated by epidemiological and
prospective studies, is associated with a reduction in plasma LDL cholesterol concentrations and a
consequent reduction in the incidence of cardiovascular and cerebrovascular events. This happens
especially when polyunsaturated and monounsaturated fatty acids are replaced with saturated fatty
acids [259].
In confirm of this, in several randomized controlled clinical studies, it was shown that the intake
of exclusively vegetable polyunsaturated fats has an effect in reducing the incidence of cardiovascular
diseases equal to 30%, a result that is similar to that obtained through statin therapy [260].
In this regard, two studies, the Lyon Diet Heart Study [212] and the Scandinavian Simvastatin
Survival Study (4Sstudy) [261], showed how the implementation of a Mediterranean dietary regime
had protective effects from the cardiovascular and cerebrovascular accidents. In fact, the Lyon Diet
Heart Study showed the incidence of coronary events and stroke was reduced by 70% in four years in
patients that practiced a Mediterranean diet. In the 4S study, instead, the intake of simvastatin reduced
recurrent coronary events by 40% in six years. It is important to note that patients enrolled in both
studies already presented a major cardiovascular event in the past.
At the moment, no study has fully cleared in subjects with acute ischemic stroke the relationship
between adherence to a MeDi style and the different diagnostic subtype or severity of stroke.
A retrospective study [262] analysed the association between MeDi adherence that was assessed
by calculating Mediterranean Diet Score (MeDi score) and TOAST stroke subtype, severity index,
and outcome of ischemic stroke. This study reported that stroke patients had a significantly lower
mean MeDi score when compared to control subjects.
Authors reported a negative association between MeDi score and National Institutes of Health
Stroke Scale (NIHSS) and Rankin scores, showing a negative relationship between adherence to a
Mediterranean diet style and severity of ischemic stroke concerning acute neurological deficit at
admission and disability at discharge.
The MeDi Score significantly varies in relation to the stroke subtype. In fact, the Large Artery
Atherosclerosis stroke (LAAS) had a low-to-medium score as compared to the lacunar subtype and
cardio-embolic subtype. This suggests an inverse relationship between adherence to the Mediterranean
diet and atherothrombotic pathogenesis of ischemic stroke. The results that were obtained suggest that
patients with a lower MeDi score are more susceptible to developing ischemic strokes. Although some
plausible bio-molecular mechanisms underlying this correlation have been validated, it is necessary to
carry out further studies that aimed at evaluating the different degrees of acute inflammation in the
post-ictal phase in relation to the dietary regime practiced by the patient.
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7. Conclusions
Over the past few decades, there has gradually been an increase in awareness that dietary pattern
affects health, in particular numerous studies have reported notable effects of nutritional components
on metabolic functions of organisms and pathological processes (See Figure 3). Among several dietary
pattern, the Mediterranean diet has been widely recognized as a model of “healthy eating”, because
of its contribution to the state of health and its positive influence on quality of life. The traditional
Mediterranean diet consists of a wide range of minimally processed whole grains and legumes, fresh
vegetables, fresh fruits, cold pressed extra virgin olive oil, nuts, and seeds as the principal source of fat,
moderate consumption of fish, low amounts of dairy products, very low frequency of intake of red and
processed meat, and wine consumed in low to moderate amount.
Between 2006 and 2010, subsequent interesting studies highlighted the role of virgin olive oil in
the modulation of endothelial function in the context of a Mediterranean dietary regimen. It is now
known that the Mediterranean diet has undoubted health benefits compared to other dietary patterns,
however some studies, after a careful reassessment, suggest that the Mediterranean diet is not free
from defects and some researchers have exposed criticism and doubts. In the light of these reflections,
the exponents of international institution, while taking the evolution of the Mediterranean diet into
account, proposed a new food pyramid for the modern Mediterranean diet. The modern food pyramid
has a lower base that emphasizes the importance of a daily adequate level of physical activity and it
suggests a minimal consumption of alcohol and supplements of vitamins and minerals.
Animal and human translational studies have recently brought to light some biological processes
that seem to mediate the beneficial effects of the Mediterranean diet. The Mediterranean diet is the
most studied dietary pattern at the level of evidence-based medicine. The high intake of fiber rich
energy poor plant foods, the reduced content of sulfur and branch chain amino acids, and saturated
fatty acids represent some of the most important elements that mediated the positive and pro-longevity
effects of this dietary pattern. The gut microbiome is emerging as a relevant key factor that influences
metabolic and molecular health; these effects are mediated by processing of numerous plant foods
packed with fiber, vitamins, and phytochemicals. Nutritional genomics include several aspects of
nutrition related molecular processes, such as transcriptomics, genomics, metabolomics, and genetics
To date, the current metabolomic literature, which has already identified specific important
metabolites that result from the ingestion of unique diets and that influence health status, has reported
interesting but often inconclusive evidence about Mediterranean diet and microbioma relationship,
however it appears clearly defined the role of gut microbiome in contributing to the beneficial healthy
effects associated with the Mediterranean diet.
Further mechanisms are certainly involved, thus further researches are needed to clarify known
mechanisms and understand other processes underlying the interactions among food and nutrients,
intake, single nutrient changes, microbiota, physical exercise, genetic predisposition, and their effects
in modulating specific molecular pathway responsible of cellular, tissue, and organ function during
aging [263–267].
The knowledge of gene-diet interaction is actually limited and still evolving. The studies on
epigenome changes are helping to clarify and understand diversities in individual susceptibility,
thus this research also aims to develop epigenomic drugs and look forward foods and supplements
that will modulate epigenome.
In the light of these premises, it is desirable to promote scientific researches regarding genetic
and biomolecular mechanisms that, besides giving a better explanation of the cause-effect relation
between adherence to Mediterranean diet and reduction of cardiovascular diseases, it will provide the
opportunity of personalizing the dietary regimen of a specific subject while also taking into account
his genetic susceptibility.
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